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ABSTRACT 
 
Sex differences in stress and anxiety disorders are well reported in the clinical 
population.  For instance, women are twice as likely to be diagnosed with post-traumatic 
stress disorder (PTSD) compared to men.  This difference is most profound during the 
reproductive years suggesting a role for sex hormones and their metabolites in regulating 
fear and anxiety.  Previous studies suggest sex differences also occur in rodents, which is 
modulated by gonadal hormones.  Despite the majority of clinical cases occurring in 
women, most rodent studies only include male subjects.  An understanding of what 
contributes to this disparity is necessary for sex-specific therapies and interventions.  
Here, we use Pavlovian fear conditioning, a learned task in which male rats display 
higher fear levels compared to females, to understand the neurobiological basis for sex 
differences in fear and anxiety. Specifically, we focus on allopregnanolone (ALLO), a 
metabolite of progesterone and potent allosteric modulator of GABAA receptors and its 
effects in the bed nucleus of the stria terminalis (BNST) in male and female rats.  The 
BNST is a sexually dimorphic brain region and site of hormonal modulation that has 
been implicated in contextual fear.  Raising ALLO levels in the BNST of male rats 
successfully impaired contextual fear and blocking ALLO in the BNST of female rats 
successfully increased contextual fear.  However, impairing contextual fear via ALLO in 
male rats proved to be the result of state-dependent learning, which was unique to the 
BNST as global impairments in both contextual and cued fear to ALLO were found in 
the basolateral amygdala.  In females, hormonal changes across the rodent estrous cycle 
  iii 
follow similar patterns to that of the menstrual cycle in women and provide a naturalistic 
model to observe changes in fear responses at the cellular level when ALLO levels are 
high or low due to progesterone fluctuations.  Results suggest naturally circulating 
progesterone may also contribute to state-dependent contextual fear; however, 
ovariectomized rats administered progesterone do not.  The work presented here aims to 
elucidate the mechanisms underlying ALLO’s influence on sex differences in fear and 
anxiety and contribute to the growing body of literature on women’s health.   
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CHAPTER I  
INTRODUCTION  
 
Sex Differences in Fear and Anxiety 
Anxiety is a normal response to threat, novelty, or stress in everyday life.  
However, when anxious behavior persists in the absence of threatening or stressful 
stimuli, various psychiatric disorders may arise.  Anxiety disorders are among the most 
common mental disorders in the U.S. with an estimated lifetime prevalence of 31% 
(Kessler et al., 2009) and a 12-month prevalence rate of 18.1% of which 22.8% are 
considered serious in terms of severity (Kessler et al., 2005b). Unsurprisingly, given the 
high number of diagnoses, anxiety disorders have devastating effects on society 
including decreased work performance, medical costs, and mortality when presented 
with comorbid disease (Greenberg et al., 1999; Smoller et al., 2007).   
Importantly, there is a considerable sex difference in the rates of diagnoses with 
those for women far exceeding those for men (Kessler et al., 1994; 1995; 2006; Tolin 
and Foa, 2006).  Overall, the lifetime prevalence rate of any anxiety disorder is 30.5% in 
women compared to 19.2% in men (Kessler et al., 1994).  This pattern is consistent over 
a wide variety of anxiety and fear-related disorders including panic disorder, 
agoraphobia, social phobia, generalized anxiety disorder, and posttraumatic stress 
disorder (PTSD).  In particular, women are twice as likely to be diagnosed with PTSD 
compared to men. These findings are not due to women witnessing traumatic events 
more than men: in fact, men and women do not differ in exposure to a traumatic event.  
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Overall, the greatest indicator of development of PTSD was preexisting anxiety 
disorders (Breslau et al., 1997).  This suggests that women are more susceptible to 
prolonged negative emotional reactions to stressful and traumatic life events that 
ultimately may lead to anxiety disorders.  Many overlapping factors may contribute to 
this susceptibility, including sex differences in the structure and function of the brain, the 
hypothalamic-pituitary-gonadal axis, the hypothalamic-pituitary-adrenal axis (HPA), and 
memories of emotional events (Canli et al., 2002; Goel et al., 2014; Ingalhalikar et al., 
2014; Toufexis et al., 2014).   
Fear and anxiety studies in rodents also show sex differences.  Sex differences 
related to anxiety in rodents, however, are less clear.  On a number of tests including the 
elevated plus maze, light-dark box, open field test, Vogel punished drinking test, and 
contextual fear conditioning, female rodents actually have decreased fear and anxiety 
behavior compared to males (Barker and Galea, 2010; Johnston and File, 1991; 
Marcondes et al., 2001; Maren et al., 1994; Markus and Zecevic, 1997; Ramos et al., 
2002; Steenbergen et al., 1990; van Haaren et al., 1990; Zimmerberg and Farley, 1993).  
However, other studies have found no sex differences or the opposite pattern (Chang et 
al., 2009; Frick et al., 2000; Johnston and File, 1991; Marcondes et al., 2001; Nomikos 
and Spyraki, 1988; Pryce et al., 1999).  Many factors may contribute to this including 
time of testing (Marcondes et al., 2001), testing conditions (Mora et al., 1996), and 
whether or not the estrous cycle was considered (Markus and Zecevic, 1997).  
In the laboratory, certain aspects of PTSD can be modeled using Pavlovian fear 
conditioning, including learned fear behaviors, extinction of fear, and generalization 
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(Milad and Quirk, 2012; VanElzakker et al., 2014).  A previously innocuous cue 
(conditioned stimulus, CS) is paired with an aversive stimulus, such as a footshock 
(unconditioned stimulus, US).  After repeated pairings, the CS alone predicts the US and 
results in fear-like behavior.  Specifically, freezing behavior is used as an index of fear 
by measuring immobility aside from what is necessary for respiration.  Conditioned fear 
develops not only to the specific CS, but also to the distinct context in which training 
occurs as characterized by particular odors, lighting, or structural constraints within the 
environment.  Freezing to the context in the absence of aversive stimuli is a measure of 
contextual fear whereas freezing to presentations of the CS in a novel context is a 
measure of cued fear.  
 
Hormonal Control of Fear 
Menstrual Cycle vs. Estrous Cycle 
 While initially there may seem to be a discrepancy between human clinical data 
and rodent studies of fear and anxiety (where women have higher rates of anxiety and 
female rodents overall show decreased anxiety), there are nonetheless many similarities.  
First, women and female rodents share similarities in the cyclical fluctuations of gonadal 
hormones over time.  In humans, the menstrual cycle, averaging 28 days, begins in the 
follicular stage when levels of progesterone and estrogen are low.  Estrogen levels spike 
causing a surge in luteinizing hormone (LH) and follicle-stimulating hormone (FSH), 
which stimulates ovulation.  After ovulation, estrogen levels remain elevated and 
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progesterone levels rise, leading to the luteal phase.  Estrogen and progesterone levels 
then diminish and the cycle repeats (McLachlan et al., 1987). 
 While the rodent estrous cycle is different from the menstrual cycle, the 
fluctuations in hormones are relatively similar, making rodents a useful model for 
studying the effects of hormone level changes on behavior.  The 4-5 day estrous cycle 
consists of proestrus, estrus, metestrus, and diestrus stages (in 5-day cycles, diestrus or 
estrus may last for two days).  Low hormone levels correspond with the follicular phase 
in humans and high hormone levels correspond with the mid-luteal phase when estrogen 
and progesterone are elevated (Emanuele et al., 2002).  Estrogen levels remain low in the 
diestrus phase while progesterone has a slight rise in the early part of diestrus.  During 
proestrus, estrogen levels rise followed by a surge in LH and FSH, stimulating ovulation.  
After the rise in estrogen, progesterone is acutely elevated and then drops and the cycle 
repeats (Smith et al., 1975).  Given the relatively similar hormonal profiles in both 
humans and rodents, the shortened rodent cycle provides an ideal model for study due to 
its brevity.  Caution must be given to the specific time periods that testing occurs as well 
as the light cycle; simple factors such as these can drastically change behavioral 
outcomes.  Estrous cycle stage is easily determined in rodents via vaginal smearing and 
cellular profiling (Goldman et al., 2007).  However, simply testing subjects at different 
stages of the estrous cycle does not necessarily answer the question of the role of 
hormones in behavioral tests of anxiety.  Because estrogen and progesterone rise and fall 
in relatively the same time periods, further analysis must be done to decipher the role of 
each of these hormones and its metabolites individually.    
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 Because of similarities in cycling hormones between humans and rodents, 
comparisons can be made between low levels of hormones (diestrus), and high levels of 
hormones (proestrus).  Similarities exist between the two in that low levels of hormones 
corresponds with impairments of fear inhibition (Glover et al., 2013) and decreased 
extinction of fear in both humans (Glover et al., 2012; Milad et al., 2010; Zeidan et al., 
2011) and rodents (Milad et al., 2009).  Overall anxiety behaviors are also decreased 
during periods of elevated hormones across both the estrous and menstrual cycle 
(Llaneza and Frye, 2009; Marcondes et al., 2001; Pigott, 2003; Wegerer et al., 2014).  
During menopause (51-55 years of age), women have higher rates of PTSD.  However, 
lower levels of PTSD are observed during postmenopausal periods (Ditlevsen and Elklit, 
2010), further supporting the role in fluctuating hormones contributing to greater PTSD 
diagnosis.  Therefore, it may not be absolute levels of hormones during different stages 
of the cycle but the constant fluctuations and change in hormone supply that contributes 
to sex differences.  It is likely not one specific hormone that modulates fear memories, 
but rather a combination of each and its metabolites that affect behavior.   
 
Hormones & Sex Differences in Fear Conditioning 
 Earlier work first established a sex difference in rodents on fear conditioning 
(Maren et al., 1994).  Initially, sex differences were found in the magnitude of induced 
long-term potentiation (LTP) in the dentate gyrus, a component of the hippocampal 
system.  After high-frequency stimulation of the performant path (the major afferent 
input of the dentate gyrus), females displayed weaker LTP than that in males.  Due to the 
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role of hippocampal LTP in contextual learning, sex differences were examined in both 
hippocampus-dependent and hippocampus-independent forms of fear conditioning.  
Robust sex differences were observed in contextual fear conditioning, a hippocampus 
dependent task.  At both low and high shock intensities, male rats showed greater 
freezing behavior compared to female rats.  In contrast, male and female rats did not 
show differences in the amount of freezing to an auditory CS after either 1 or 3 trials.  
However, when tested in the same context used for conditioning, males again showed 
greater freezing behavior (Maren et al., 1994).   
After this seminal discovery, subsequent work sought to determine whether 
gonadal steroids contributed to these sex differences.  In the first set of experiments, 
male rats were castrated to examine the effects of circulating testosterone on contextual 
fear.  No differences were reported during acquisition or extinction of fear between 
castrated males, castrated males with testosterone replacement, or unoperated controls.  
Furthermore, when compared to females, both castrated and intact males had higher 
freezing levels compared to females (Anagnostaras et al., 1998).  Therefore, activational 
effects of testosterone do not mediate sex differences in contextual fear.  In contrast, it 
was found that ovariectomized female rats froze at comparable levels to males, both of 
which were higher than sham-operated females following contextual fear conditioning.  
Estrogen replacement in ovariectomized females reduced freezing to that seen in sham 
operated groups (Gupta et al., 2001).  When examining estrogen’s effects on LTP, it was 
found to reduce hippocampal LTP (Gupta et al., 2001).  Together, this body of work 
established a sex difference in fear conditioning between male and female rodents and 
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identified a role for ovarian steroids in mediating this observed difference.  The work in 
this dissertation therefore focuses on the contributions of female sex hormones, 
particularly estrogen, progesterone, and their metabolites and their influence on fear 
conditioning.  
 
Estrogen 
Synthesis 
 Estrogen is synthesized from locally produced androgens through the enzymatic 
actions of aromatase (Naftolin et al., 1975).  Specifically, estrone is synthesized from 
androstenedione and estradiol from testosterone.  Estrone can be converted to estradiol 
and vice versa via 17-hydroxysteroid-dehydrogenase, and then can be converted to 
estriol.  Estrone is primarily secreted during menopause and estriol during pregnancy 
(Gruber et al., 2002).  Estradiol is the most dominant and potent estrogen acting at 
estrogen receptors during the reproductive years and therefore will be the focus of this 
section.  In premenopausal females, the majority of estrogen is synthesized from the 
ovaries, which then enters the bloodstream to affect target organs.  Males also produce 
estrogen in peripheral tissue including the testes, although at much lower levels 
compared to females (Brodie and Inkster, 1993).  Aromatase activity has also been found 
in both male and female rodent, primate, and human brains, suggesting local synthesis 
and availability (Naftolin et al., 1975; Roselli and Resko, 2001; Stanić et al., 2014).  
Importantly, aromatase activity has been localized to key brain regions implicated in 
anxiety including the hypothalamus, amygdala, bed nucleus of the stria terminalis, 
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hippocampus, and cingulate cortex (Hojo et al., 2004; Jakab et al., 1993; Kretz et al., 
2004; Tabatadze et al., 2014).  The availability of locally synthesized estradiol suggests 
it may modulate anxious behavior.   
Mechanisms of action 
Estrogen exerts its effects at a number of different receptors to affect behavior.  
Classically, estrogen was thought to act on nuclear receptors ERα and ERβ to initiate 
transcription of genes (Green et al., 1986; Kuiper et al., 1996).  This effect is considered 
to be a long-term, genomic effect that could take anywhere from hours to days.  Due to 
the lipophilic nature of estrogens, they readily cross the cell membrane and act as ligands 
to ERα and ERβ in both the cytoplasm and nucleus.  Once activated, the receptors 
translocate to the nuclear DNA domain and bind to estrogen-response-elements (ERE) to 
alter the rate of gene expression through the recruitment of coactivator or corepressor 
proteins (Gruber et al., 2002).  Evidence suggests estrogen receptors may also be located 
on the cell surface (Mitterling et al., 2010; Spencer et al., 2008).  Both ERα and ERβ are 
present in the limbic system although the distribution is not always overlapping (Cover 
et al., 2014; Osterlund et al., 1998; Shughrue et al., 1997).  Additionally, receptors are 
noted to change over the course of the estrous cycle and after ovariectomy (Bowlby et 
al., 2015; Haywood et al., 1999; Mitterling et al., 2010; Shughrue et al., 1992).  When 
considering the endogenous or exogenous actions of hormone administration on anxiety, 
it is therefore important to consider the diverse and changing receptor profiles.     
 More recently, a novel receptor with high affinity for estrogen was discovered.  
GPR30 is a G-protein coupled receptor (GPCR) that evokes rapid, nongenomic effects, 
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unlike the classical nuclear receptors.  Current research has begun to elucidate the role of 
this receptor in behavioral and emotional processes (Hammond et al., 2009).  GPR30 has 
been found in cell membranes as well as intracellularly in the endoplasmic reticulum.  
Unlike many other GPCRs, estrogen binds to GPR30 intracellularly (Revankar et al., 
2007).  Binding of estrogen to this receptor initiates a number of intracellular signaling 
cascades including mobilizing calcium stores, cyclic adenosine monophosphate (cAMP), 
mitogen-activated protein kinases (MAPKs) and phosphatidylinositol 3-kinases (PI3Ks) 
(Prossnitz et al., 2008).  Mouse studies found GPR30 labeling in regions implicated in 
fear and anxiety including the hippocampus, amygdala, BNST, and hypothalamus 
(Hazell et al., 2009).  As research progresses, estrogen’s effects on fear and anxiety can 
no longer be strictly defined to the genomic actions of classical estrogen receptors, ERα 
and ERβ, but must also include the rapid actions at GPR30 and membrane bound ERs.   
Estrogen and fear 
 It is well established that estrogen affects learning in many different paradigms 
and has been found to both facilitate and impair fear learning.  In support of anxiolytic 
actions of estrogen, cycling rats in proestrus display reduced fear, but enhanced learning, 
in the two-way avoidance paradigm (Sfikakis et al., 1978) as well as OVX rats 
chronically treated with estradiol (Singh et al., 1994).  However, in opposition, Diaz-
Veliz et al. (1989; 1991; 2000) found estrogen to increase fear on the two-way avoidance 
task and decrease learning in cycling and OVX rats.  Learning was strengthened in 
diestrus animals and decreased in proestrus (Diaz-Veliz et al., 1989).  In OVX rats, 
learning was enhanced and estrogen administration decreased acquisition (Diaz-Veliz et 
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al., 1991; 2000).  More research is necessary to understand estrogen’s role in this 
paradigm.  In fear conditioning models, rats in proestrus froze significantly less to 
contextual fear compared to estrus rats and males, but showed no difference to cued fear 
(Markus and Zecevic, 1997).  Furthermore, when ovarian supply of estrogen is 
eliminated via OVX, rats displayed levels of context fear comparable to males, and 
estrogen administration prior to conditioning reduced freezing (Gupta et al., 2001).  
There are reports, however, of no effect as well with administration of exogenous 
estrogen to GDX and OVX rats on light-enhanced startle or CRF-enhanced startle 
(Toufexis et al., 2005; 2004) or across the estrous cycle and in OVX rats with estrogen 
replacement in context fear conditioning (Chang et al., 2009).  An increase in context 
and cued fear related to estrogen was also found (Morgan and Pfaff, 2001; Jasnow et al., 
2006).  ERβ-KO mice had reduced context fear in females and reduced context and cued 
fear in males, suggesting a possible mechanism for this effect (Day et al., 2005).  Similar 
increases in fear were also found on tests of fear-potentiated startle (Hiroi and Neumaier, 
2006).  Interestingly, sex differences were found in passive avoidance with estrogen 
enhancing retention in males, but inhibiting retention in females (Mora et al., 1996; 
Vázquez-Pereyra et al., 1995).  Estrogen was also found to increase generalization of 
fear responses in females which may be mediated by actions of ERβ (Lynch et al., 2013; 
2014). 
 Research on the role of estrogen in extinction learning, on the other hand, has 
been surprisingly consistent.  Sex differences were absent in conditioning, extinction, 
and recall until estrous cycle was taken into consideration.  Rats show enhanced 
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extinction during the proestrus phase compared to metestrus rats and male rats as seen in 
the recall test 24 hours later (Milad et al., 2009; Rey et al., 2014).  The deficit seen in 
metestrus rats was rescued via exogenous administration of estrogen immediately after 
extinction learning, but not after delayed administration which corresponded with 
increased fos in the IL and decreased fos expression in the amygdala (Milad et al., 2009; 
Zeidan et al., 2011).  Furthermore, blocking estrogen receptors prior to extinction 
learning impaired consolidation (Milad et al., 2009).  In addition to naturally cycling 
  
Task 
Hormonal 
State Effects on Fear Study 
Extinction Proestrus 
decrease 
freezing Milad et al., 2009 
Metestrus increase freezing  
Extinction 
Estrus increase freezing 
Rey et al., 2014 
Metestrus increase freezing 
Diestrus increase freezing 
Proestrus  
decrease 
freezing  
Extinction 
OVX + 
estrogen 
decrease 
freezing  
Chang et al., 
2009 
Extinction  
OVX + 
estrogen  
decrease 
freezing 
Gupta et al., 
2001 
Table 1 Summary of estrogen’s effects on fear extinction. 
 
 
rats, ovariectomized rats administered estradiol directly into the hippocampus also 
display enhanced extinction learning (Chang et al., 2009).  Similar effects were also seen 
when estrogen receptor agonists were administered to rats on hormonal contraceptives 
with reduced estradiol levels (Graham and Milad, 2013).  Estrogen does not appear to 
only be important for extinction learning in females; in males, inhibition of estradiol 
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synthesis during extinction training impairs fear extinction, which can be reversed by co-
administration of estradiol (Graham and Milad, 2014).  Further examination reveals a 
specific role of ERβ in mediating enhanced extinction learning.  Administration of ERβ 
selective agonists specifically facilitated this effect (Chang et al., 2009; Zeidan et al., 
2011).   
 Estrogen clearly enhances extinction learning and it appears to be mediated by 
ERβ not ERα.  However, the confounding literature on other learning tasks related to 
fear and anxiety creates a more complicated picture.  Enhanced extinction learning is 
associated with decrease fear, yet in a number of studies discussed, estrogen increased 
fear (Hiroi and Neumaier, 2006; Jasnow et al., 2006; Morgan and Pfaff, 2001).  
Increased fear after acquisition suggests enhanced fear learning.  Estrogen therefore may 
not simply cause increases or decreases in freezing behavior, but enhance the learning 
mechanisms that are responsible for the presentation of fear.  A number of these studies 
used OVX female rats, which discounts the possibility of fluctuating hormones in 
mediating these effects.  In addition, Toufexis et al. (2006) used a discrimination 
learning paradigm to further assess the role of ERα and ERβ and found opposing roles 
with increased responding to ERα agonists on both excitatory and inhibitory signals and 
ERβ agonists having little effect on any cues (Toufexis et al., 2006).  Complexity of the 
learning tasks and receptor distribution may therefore contribute to the varying effects 
seen in tasks such as the two-way avoidance test.   
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Humans 
Because of the inherent limitations in directly manipulating estrogen levels in 
healthy cycling humans, studies generally focus on periods in the reproductive cycle 
when estrogen levels are high (late follicular or luteal phase) or low (early follicular 
phase).  Higher estrogen levels in the menstrual cycle of females appears to enhance fear 
recognition, but not to other emotional cues (Pearson and Lewis, 2005).  Much research 
has focused on the extinction of fear in humans with findings similar to rodent studies.  
Males had greater conditioned responses compared to females in both the early and late 
follicular stage.  No differences between sexes and hormone state occurred during 
extinction learning, but during recall, only males and females with low estrogen (early 
follicular) had impaired learning (Milad et al., 2006).  Females with high estrogen 
showed enhanced extinction memory as measured by skin conductance response and this 
was also true when fear conditioning was preceded by stress (Antov and Stockhorst, 
2014; Milad et al., 2010; Wegerer et al., 2014), which was at least in part mediated by 
ventromedial prefront cortex (vmPFC) and amygdala activity (Zeidan et al., 2011).  In 
addition, women on hormonal contraceptives, which represents lower circulating 
estradiol, also had impaired extinction learning as was seen in rodent studies (Graham 
and Milad, 2013).  This was explored further in a discrimination task in which fMRI data 
revealed increased differential activation in regions critical to fear and extinction such as 
the amygdala, anterior cingulate, and vmPFC (Merz et al., 2012).  Unlike rodents, 
hormonal contributions in human populations living with anxiety-related disorders can 
be assessed.  For instance, in a traumatized population half of whom had PTSD, women 
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with low estrogen and women with high estrogen levels had similar levels of fear 
conditioning on a fear-potentiated startle task, but during extinction, startle was higher in 
those with PTSD; this difference was absent in the high estrogen group (Glover et al., 
2012).  Furthermore a comparison of healthy controls and a traumatized group found 
impaired fear inhibition in healthy and traumatized individuals with low estrogen levels 
on a discrimination task (Glover et al., 2013).  This suggests that estrogen, in part, can 
mediate the difference seen between those who proceed to develop a disorder following 
a traumatic event and those that are exposed to traumatic events but can recover.   
 
Progesterone 
Synthesis 
 Along with estrogen, progesterone is produced in significant quantities in the 
ovaries, with the biggest surge occurring during the luteal phase in humans and during 
proestrus in rats.  Progesterone, however, is not exclusive to females.  The adrenal 
glands produce progesterone in both males and females (Herrera et al., 2016; Holzbauer 
et al., 1969; Kalra and Kalra, 1977).  Synthesis also occurs in the central nervous system 
in both sexes, thus making it a neurosteroid.  Progesterone is synthesized from its 
precursor pregnenolone via 3β-hydroxysteroid dehydrogenase (3β-HSD), which has 
ubiquitous expression in the rodent and human brain (Guennoun et al., 1995; Ibanez et 
al., 2003; Inoue et al., 2002).  Allopregnanolone (ALLO) is the most studied metabolite 
of progesterone regarding fear and anxiety and is synthesized by the sequential actions 
of two enzymes.  First, progesterone is irreversibly converted to 5α-dihydroprogesterone 
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(5α-DHP) via 5α-reductase.  5α-DHP is further reduced to ALLO via 3α-hydroxysteroid-
dehydrogenase which in turn can be converted back to 5α-DHP via short-chain 
dehydrogenase reductases (Belyaeva et al., 2007).  Enzymes necessary for ALLO 
synthesis have been localized to numerous brain regions suggesting local availability and 
modulation of neuronal activation through ALLO actions (Agís-Balboa et al., 2006; 
Melcangi et al., 1993; 1998).  ALLO fluctuates in levels according to the menstrual and 
estrous cycle in a similar fashion to its precursor, however, ALLO levels have been 
found to be higher in the brain than in the plasma (Bixo et al., 1997; Corpéchot et al., 
1993; Droogleever Fortuyn et al., 2004).   
Mechanisms of action 
Progesterone binds to a number of receptors to produce both genomic and non-
genomic actions.  Classically, progesterone binds to intracellular receptors causing 
conformational changes and release of chaperone proteins to allow progesterone binding 
with progesterone response elements at target genes for gene upregulation or 
downregulation.  Progesterone receptors (PR) come in two isoforms, PR-A and PR-B, 
which may have differing roles (Jacobsen and Horwitz, 2012).  Both are widely 
expressed within the brain and do not appear to have neuronal specificity.  Specifically, 
PRs are expressed in the hippocampus, frontal cortex, and amygdala with especially high 
levels of expression in the BNST (Guerra-Araiza et al., 2001; 2002; Kato et al., 1993).  
Importantly, PR expression fluctuates with the estrous cycle in certain brain regions such 
as the hypothalamus and frontal cortex, but not in the hippocampus (Guerra-Araiza et 
al., 2000; 2003).  Even though classical PRs are thought to be genomic in nature, there is 
  16 
evidence of non-genomic actions of PRs via Src kinase (Boonyaratanakornkit et al., 
2001).  PR-A and PR-B are not the only binding sites of progesterone.  Although many 
nongenomic actions of progesterone are attributed to its metabolite, ALLO, there is still 
evidence of progesterone actions at membrane bound receptors.  Recent advances have 
identified a number of membrane receptors specific to progesterone although their 
localization and function in the central nervous system is only just beginning to be 
understood.  One such class of receptors is progesterone receptor membrane component 
1 and 2 (Pgrmc1, Pgrmc2), which are located throughout the brain, including the limbic 
region (Intlekofer and Petersen, 2011; Krebs et al., 2000).  Studies suggest Pgrmc1 
cannot act independently, but requires serpine mRNA binding protein 1 (Serbp1) to act 
as a binding partner (Peluso et al., 2006).  In addition, receptors in the PAQR family 
have been identified as potential targets: Paqr7 and Paqr8 (mPRα and mPRβ) which are 
coupled to G-proteins and regulate both cAMP and MAPK (Tang et al., 2005; Thomas et 
al., 2007; Zhu et al., 2003).  Although brain analyses have identified these receptors, 
their exact role in neurons is still being questioned (Fernandes et al., 2008).  Future 
research is necessary to elucidate the role of these novel progesterone receptors in fear 
and anxiety.  
 Allopregnanolone does not act at classical progesterone receptors, but instead 
acts as a potent positive allosteric modulator of GABAA receptors (Majewska et al., 
1986).  At low concentrations, ALLO promotes the open state of the GABAA ion 
channel and at high concentrations can directly activate the receptor in the absence of 
GABA (Callachan et al., 1987).  Recent work has localized the binding site of ALLO to 
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the α-subunit transmembrane domains and a site between α and β subunits when directly 
activating the receptor (Hosie et al., 2006; 2009).  There is a wide variation in subunit 
compositions of GABAA receptors as well as localization of GABAA receptors to either 
the synapse or extrasynaptic space.  ALLO appears to have effects at multiple subunit 
compositions as well as at synaptic and extrasynaptic GABAA receptors, however 
different concentrations may be necessary for a response.  The response of ALLO at 
GABAA receptors can be heterogeneous; ALLO actions at GABAA receptors in one 
brain region may not have identical responses in other brain regions or in other neurons 
in the same region, which may be due in part to subunit composition (Belelli and 
Lambert, 2005).  Despite the differences in subunit composition, overwhelming evidence 
points to ALLO having much stronger effects at δ subunit-containing GABAA receptors 
(Belelli et al., 2002; Wohlfarth et al., 2002).  Relatively low concentrations of ALLO are 
needed to modulate these receptors.  Delta subunit-containing receptors are extrasynaptic 
and produce a tonic inhibitory tone on the cell as opposed to a phasic tone on synaptic 
receptors.  Subunit composition changes over the course of the estrous cycle, such as in 
the hippocampus (Maguire et al., 2005), allow ALLO to modulate inhibitory tone at 
varying degrees within the brain.  In addition to GABAA receptors, ALLO may also act 
on mPRα although this has only been studied in neuronal cell lines (Thomas and Pang, 
2012) and also on pregnane xenobiotic receptor (PXR; Lamba et al., 2004).  
Progesterone and fear 
On conditioned measures of fear, progesterone and ALLO have been shown to 
both increase and decrease fear, although a closer examination of these data may account 
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for this discrepancy.  Fear conditioning literature in rats and mice have varying results 
with progesterone on freezing behavior, however, there are consistent results regarding 
its effects on context versus cued fear.  In a number of different studies, progesterone’s 
effects on cued fear appear to be nonexistent.  For instance, when comparing fear 
potentiated startle (FPS) to corticotropin-releasing factor-enhanced startle (CRF-
enhanced startle), an effect of progesterone was only observed in the CRF-enhanced 
startle, a task which is thought to be contextual in nature as opposed to the FPS, which is 
more cue-dependent (Toufexis et al., 2004).  Furthermore, progesterone’s effects at 
reducing CRF-enhanced startle are thought to be due to ALLO, as ALLO had similar 
effects and medroxyprogesterone, which cannot be metabolized to ALLO blocked the 
effect (Toufexis et al., 2004).  A similar effect was seen in male mice administered 
ALLO systemically prior to context pre-exposure; during context testing, those that 
received ALLO had decreased freezing whereas no effects were observed during tone 
testing (Rabinowitz et al., 2014).  Therefore, ALLO appears to selectively reduce 
contextual fear.  In contrast to this, OVX mice treated with progesterone after training 
showed increased contextual and cued fear (Frye and Walf, 2008), suggesting 
progesterone and ALLO may have different roles in conditioned fear regarding 
consolidation versus expression.   
Regarding extinction learning, female rats that were extinguished during the 
proestrus phase consolidated the memory better than those in metestrus as seen by 
reduced freezing on the recall test the following day (Milad et al., 2009).  While this 
could be due to both estrogen or progesterone, as exogenously administering estrogen or 
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progesterone during metestrus reversed this, blocking progesterone receptors during 
proestrus eliminated the decreased freezing during recall, suggesting progesterone is in 
some way involved (Milad et al., 2009).  However, in an OVX model, timing of 
progesterone administration appears to be critical; progesterone administered six hours 
prior to extinction enhanced recall, but impaired it when administered 24 hours prior.  In 
further support, blocking progesterone receptors in proestrus during extinction prevented 
the increase in fear during recall as seen during metestrus (Graham and Daher, 2015).   
 Progesterone withdrawal has also been linked to anxiety.  In both withdrawal 
paradigms after exogenous progesterone administration and in natural fluctuations across 
the estrous cycle, declining progesterone is associated with an anxiogenic response 
(Koonce et al., 2012; Lofgren et al., 2006; Mora et al., 1996; Smith et al., 1998).  
Although these tests were not specific to conditioned fear, they suggest fluctuating 
progesterone levels change anxiety profiles.  Mechanistically, this has been linked to 
changes in GABAA subunit expression, suggesting a role for ALLO (Griffiths and 
Lovick, 2005; Lovick et al., 2005; Smith et al., 1998). 
The socially isolated male mouse has served as a model for PTSD as evidenced 
by its increase in anxiety and aggressive behavior.  Disruption of ALLO levels have 
specifically been linked to this effect (Pinna et al., 2003).  Decreased ALLO levels 
coincided with decreased levels of 5α-reductase in crucial corticolimbic regions (Agís-
Balboa et al., 2007).  Once again, these irregularities in ALLO levels correspond to 
increased contextual fear with no effects on cued fear which specifically correlated with 
decreased 5α-reductase in the amygdala and hippocampus (Pibiri et al., 2008).  Further 
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supporting a beneficial role of ALLO in treating PTSD, ganaxolone, a synthetic version 
of ALLO has been shown to facilitate extinction of context fear in this model (Pinna and 
Rasmusson, 2014) and many drugs have been shown to be effective through 
upregulation of ALLO (Ugale et al., 2007; Uzunov et al., 1996).  Together, progesterone 
and its metabolite ALLO appear to preferentially affect contextual fear processing, 
although the exact mechanisms behind this, remain to be discovered. 
Humans 
The influence of progesterone and ALLO on both healthy individuals and those 
diagnosed with psychiatric disorders mirrors many of the studies done in rodent models.  
In humans, progesterone rises during the luteal phase and tapers off to low levels in the 
follicular phase.  Many anxiety-related symptoms are reported in women during this 
time of hormonal flux in healthy subjects and clinical patients (Breier et al., 1986; 
Gonda et al., 2008).  Similar to the literature on progesterone withdrawal in rodents, 
diminishing levels of progesterone may also contribute to increased anxiety in humans.  
This is particularly important in premenstrual syndrome (PMS) and its extreme variant 
premenstrual dysphoric disorder (PMDD), both of which involve anxiety symptoms 
(Angst et al., 2001; Vickers and McNally, 2004).  In patients with PMS, ALLO levels 
during the luteal phase were lower than healthy controls and progesterone levels were 
lower in both the luteal and follicular phases (Monteleone et al., 2000), but rising ALLO 
levels also correlated with adverse moods such as irritability (Backstrom et al., 2003).  
These discrepancies suggest that absolute levels of ALLO may not be the contributing 
factor, but overall sensitivity changes to GABAA receptors as subunits change (Epperson 
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et al., 2002).  This is further supported by the receptor subunit changes observed in 
animal models.  Interestingly, progesterone administered to healthy subjects during the 
follicular phase when levels are typically low resulted in increased amygdala activity 
(van Wingen et al., 2008).  Increased amygdala activity is thought to correlate with 
increased anxiety; however, these results could be due to a sudden increase in ALLO 
levels at a time when this does not naturally occur.    
Human studies of extinction learning, which largely model therapies for PTSD, 
do not convincingly show a role for progesterone.  In fact, levels of progesterone did not 
correlate with fear acquisition, extinction, or recall (Milad et al., 2010; Wegerer et al., 
2014).  However, patients with PTSD have lowered ALLO levels compared to controls 
(Rasmusson et al., 2006).  In clinical populations, there also appears to be a dysfunction 
in GABAergic neurotransmission, specifically with a decrease in GABA levels (Vaiva et 
al., 2004) and decreased activity of benzodiazepines (Bremner et al., 2000).  One 
hypothesis for the lack of success with benzodiazepines could be due to changes in 
GABAA receptor subunit expression that do not bind benzodiazepines, but still would be 
responsive to ALLO.  Because of the ineffectiveness of benzodiazepines in treating 
PTSD (Davidson, 2004), efforts should be made to consider allopregnanolone or its 
synthetic analogues in the treatment of PTSD. 
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Neuroanatomical Substrates for Sex Differences in Fear and Anxiety 
Amygdala 
 Seminal work identifying the role of the amygdala in fear behavior came from 
Kluver and Bucy (1937).  Removing the medial temporal lobes in rhesus monkeys 
resulted in an absence of fear, anger, and aggression.  Before surgery, animals were 
fearful of their handlers, but after removal of the temporal lobes, they readily approached 
humans and objects without hesitation (Kluver and Bucy, 1937).  The lesions in Kluver 
and Bucy’s work, however, encompassed more area than just the amygdala.  Later work 
by Weiskrantz (1956) demonstrated that the loss of fear was a result of damage specific 
to the amygdala.  These initial studies provided evidence of the role of the temporal lobe, 
specifically the amygdala, in regulating fear behaviors and spawned decades of research 
that continues today.  The amygdala is composed of two main divisions: the lateral (LA), 
basolateral (BL), and basomedial (BM) nuclei, together referred to as the basolateral 
amygdala (BLA), and the central amygdala (CEA) composed of the lateral and medial 
nuclei (Krettek and Price, 1978a; McDonald, 1982).  Through its afferent sensory 
information from auditory, visual, and somatosensory inputs, the BLA, particularly the 
LA, is responsible for processing CS-US associations and subsequent fear expression 
(Fanselow and Ledoux, 1999; Maren, 1999a).  The CEA, on the other hand, is generally 
believed to be the output region of the amygdala to brain regions important for the fear 
response including the periaqueductal gray for freezing responses and the hypothalamus 
for stress responses (Ciocchi et al., 2010; Gray and Magnuson, 1987; Gray et al., 1989). 
The BLA is predominantly composed of two different neurons: pyramidal neurons and 
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interneurons.  Glutamatergic pyramidal neurons form connections within the BLA as 
well as with other regions in the amygdala and outside.  GABAergic interneurons mostly 
form local connections within the BLA (Bienvenu et al., 2012; Pape and Pare, 2010; 
Polepalli et al., 2010; Wolff et al., 2014).  The CEA, is mostly made up of GABAergic 
interneurons that contain a variety of peptides including CRH which are responsible for 
both local control and external connections (Davis et al., 1994; McDonald, 1985; Pape 
and Pare, 2010).  
 Synaptic plasticity within the BLA is necessary for conditioned fear (An et al., 
2012; Herry et al., 2008; Quirk et al., 1995) and numerous studies using lesions or 
reversible inactivation have identified the BLA as the site of CS-US convergence along 
with other indices of fear such as fear potentiated startle.  Blocking BLA actions prior to 
acquisition or expression of both contextual and cued fear impairs freezing behavior 
(Campeau and Davis, 1995; Gale et al., 2004; Goosens and Maren, 2001; Helmstetter 
and Bellgowan, 1994; Maren et al., 1996a).  Indeed, disrupting the acquisition of 
conditioned fear can still be observed at one month up to a year post-training (Gale et al., 
2004; Maren et al., 1996a).  The CEA may also be involved in fear acquisition insofar as 
CEA inactivation prior to training hinders fear learning (Ciocchi et al., 2010).  
Furthermore, with overtraining, rodents with BLA lesions are still able to acquire 
conditioned fear, which in part is mediated by the CEA (Zimmerman et al., 2007).  
Consistent with the role of the CEA as the output region of the amygdala, lesions of the 
CEA block fear expression to contextual and cued fear (Goosens and Maren, 2001; 
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Nader et al., 2001), however, the CEA is implicated in fear-potentiated startle 
(resembling cued fear), but not light-enhanced startle (Walker and Davis, 1997).   
While the amygdala, including both the BLA and CEA, is important for both the 
acquisition and expression of fear behavior, it has not received significant attention as a 
locus for hormone action in mediating sex differences.  It does contain estrogen and 
progesterone receptors (Cover et al., 2014; Guerra-Araiza et al., 2003; Hagihara et al., 
1992; Laflamme et al., 1998).  However, ERα receptors and ERβ receptors predominate 
in different nuclei (Laflamme et al., 1998; Osterlund et al., 1998).  Necessary enzymes 
for ALLO production are also present (Pibiri et al., 2008) and direct administration of 
ALLO into the CEA decreases anxiety on a variety of tasks (Akwa et al., 1999).  
Although initial experiments exploring sex differences in fear did not focus on 
the amygdala, more recent work has begun to examine its effects.  First, prolonged 
exposure to estrogen following OVX facilitates both contextual and cued fear 
conditioning which is associated with increased CRH mRNA expression in the central 
amygdala (Jasnow et al., 2006).  Female rats have greater context generalization of fear 
to similar contexts compared to males and this also correlated with greater activation in 
the amygdala of females (Keiser et al., 2017).  Estrogen may also play a role in 
modulating neuronal activity and synaptic plasticity in the amygdala following 
extinction in both rodents and humans (Zeidan et al., 2011).  Mechanistically, sex 
differences may be attributed to differences in functional connectivity (Engman et al., 
2016) or differences in synaptic plasticity due to aromatase activity within the amygdala 
(Bender et al., 2017). 
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Hippocampus 
 Due to the initial discovery of sex differences in contextual fear conditioning, 
much research has focused on the contribution of the hippocampus to sexually 
dimorphic fear behavior.  The hippocampus is believed to be responsible for encoding 
contextual information, but not specifically creating the context-US relationship.  For 
instance, hippocampal post-training lesions cause a deficit in freezing to the original 
training context (Frankland et al., 1998; Maren et al., 1997; Phillips and Ledoux, 1992; 
Selden et al., 1991), although pre-training lesions do not always cause a deficit 
(Frankland et al., 1998; Maren et al., 1997).  Although the hippocampus is not typically 
associated with cued fear conditioning, following extinction of cued fear, it is involved 
in context-dependent fear renewal.  Lesions prior to fear acquisition and after extinction 
training blocked renewal (Ji and Maren, 2005; 2008).  Thus, the hippocampus is 
important for encoding contextual fear memories.   
 Contextual representations formed in the hippocampus are relayed directly or 
indirectly to the BLA (Maren and Fanselow, 1995; Pitkänen et al., 2000).  Connections 
from the dorsal hippocampus to the BLA are important for the expression of contextual 
fear (de Oliveira Coelho et al., 2013; Huff and Rudy, 2004; Lesting et al., 2011; Maren 
and Hobin, 2007).  In addition, the ventral hippocampus, which has significant 
reciprocal connections with the amygdala (Canteras and Swanson, 1992) is also 
involved.  Reversible and irreversible inactivation of the ventral hippocampus impairs 
conditioning to contextual and auditory stimuli as well as memory retrieval (Bannerman 
et al., 2003; Bast et al., 2001; Hobin et al., 2006; Maren, 1999c; Maren and Holt, 2004).  
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Optogenetic studies suggest that BLA inputs to the ventral hippocampus promote an 
anxiogenic tone whereas inhibiting this projection is anxiolytic (Felix-Ortiz et al., 2013).  
Therefore, the hippocampus plays a critical role in contextual encoding and through its 
projections with the amygdala contributes to fear behavior.   
  Importantly, gonadal steroids heavily influence the hippocampus.  Progesterone 
and estrogen receptors are both expressed (Hagihara et al., 1992; Osterlund et al., 1998), 
but ERβ receptors, important for fear and anxiety, are more prevalent than ERα receptors 
(Foster, 2012; Mitra et al., 2003).  Estrogen is also known to change hippocampal 
morphology, which may affect its role in fear behavior.  For instance, changes in 
hormone levels across the estrous cycle influence the density of spines in the 
hippocampus (Woolley and McEwen, 1993; Woolley et al., 1990) and loss of hormones 
after ovariectomy results in a loss of spine density (Woolley and McEwen, 1993).  
Changing spine density is also important in learning and LTP (Engert and Bonhoeffer, 
1999; Parnass et al., 2000; Trachtenberg et al., 2002).  In the hippocampus, estrogen- 
induced LTP is dependent on NMDA receptors (Smith and McMahon, 2006).  Indeed, 
sex differences were first observed in dorsal hippocampal LTP with males presenting 
stronger LTP, which correlates with greater contextual freezing responses (Maren et al., 
1994).  This was later found to be modulated by estrogen (Gupta et al., 2001).  The 
ventral hippocampus also shows sex differences in extracellular signal-regulated kinase 
(ERK) phosphorylation with higher levels in males following fear conditioning (Gresack 
et al., 2009).   
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 Fear extinction is believed to be a form of hippocampal-dependent learning, such 
that hormone actions in the hippocampus are relevant for fear extinction as well.  In 
female OVX rats, intra-hippocampal estrogen, enhanced extinction, which was found to 
be dependent on ERβ (Chang et al., 2009).  Clinically, high estrogen in women is also 
associated with increased hippocampal activation during extinction recall which 
corresponds with increased extinction retention compared to low estrogen groups 
(Zeidan et al., 2011). 
 The evidence above suggests a critical role for involvement of the hippocampus 
in contextual fear and provides support for the role of hormones in mediating this effect.   
Although there is compelling evidence for the hippocampus to mediate sex differences 
in fear, other brain regions that have received less attention may be important for 
hormonal regulation and contextual fear, such as the BNST.   
 
Bed Nucleus of the Stria Terminalis 
Circuitry 
The BNST is situated in a unique position to affect fear through its connections 
with the amygdala, hippocampus, prefrontal cortex, and hypothalamus.  However, due to 
the complexity of the many different subnuclei that compose the region, it remains 
poorly understood.  The BNST is part of the extended amygdala, ventral to the lateral 
septal area, and dorsal to the hypothalamic preoptic area.  It connects with both the 
basolateral and central amygdala (BLA and CEA, respectively), ventral hippocampus 
(VH), prefrontal cortex (PFC), and hypothalamus (Figure 1; Dong et al., 2001a; 2001b; 
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Dong and Swanson, 2004), positioning it to affect freezing behavior with both afferent 
and efferent connections.   
 
 
  
Figure 1 Fear conditioning circuitry. 
Prefrontal cortex (PFC); hippocampus (HPC); bed nucleus of the stria terminalis (BNST); central 
amygdala (CEA); basolateral amygdala (BLA); hypothalamus (HYP). 
 
 
 
Specifically, the intricate connections from the amygdala differentially target the 
BNST.  The basal nuclei projects to the BNST, however the basomedial region 
preferentially targets the anteromedial region of the BNST (BNST-AM) whereas the 
basolateral region preferentially targets the anterolateral region of BNST (BNST-AL) 
(Dong et al., 2001a; Krettek and Price, 1978b).  Interestingly, the projections from the 
basolateral region to the BNST-AL exclude the oval nuclei (BNST-OV; Dong et al., 
2001a), but BLA to BNST-anterodorsal pathway appears to produce an anxiolytic tone 
(Crowley et al., 2016; Kim et al., 2013).  The CEA and the BNST have long been known 
to be anatomically and neurochemically similar.  Both receive glutamatergic inputs from 
the BLA (Dong et al., 2001a; Krettek and Price, 1978b) and largely project to the same 
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regions of the hypothalamus except the BNST projects to the paraventricular nucleus of 
the hypothalamus and the CEA does not (Dong et al., 2001b; Dong and Swanson, 2006; 
Prewitt and Herman, 1998).  There are also reciprocal projections between the two 
regions such that the CEA sends GABAergic projections mainly to the BNST-AL and 
the BNST sends projections back to the CEA via the BNST-AL and BNST-AV regions 
(Dong et al., 2001b; Dong and Swanson, 2004; Gungor et al., 2015). 
Outside of the amygdala and relevant to fear circuitry, the BNST (dorsalmedial 
and fusiform nuclei) receives glutamatergic projections from the infralimbic cortex 
(Dong et al., 2001a; Radley et al., 2009) whereas it receives glutamatergic projections 
from the ventral subiculum mainly to the BNST-AM (Cullinan et al., 1993; Dong et al., 
2001a; Radley and Sawchenko, 2011).  Within the BNST there are vast intrinsic 
connections as well (Turesson et al., 2013). 
Contextual fear 
Importantly, the BNST is implicated in contextual fear.  Both electrolytic lesions 
and reversible inactivation of the BNST selectively impairs contextual fear, but has no 
effect on auditory cued fear (Hammack et al., 2004; Resstel et al., 2008; Sullivan et al., 
2004; Zimmerman and Maren, 2011).  This distinction may depend on the length of the 
auditory cues as very long cues depend on BNST activity (Waddell et al., 2006; Walker 
et al., 2009) as well as when the US is delivered (Hammack et al., 2015).  Inactivating 
the BNST also impairs fear to unconditioned stimuli such as bright lights (Walker and 
Davis, 1997), and predator odor (Fendt et al., 2003; Xu et al., 2012) where the threat is 
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present throughout the entire test.  Therefore, the BNST appears to be important for 
contextual information, however what constitutes contextual information is subjective.  
Neuroendocrine properties 
The BNST regulates a number of sexually dimorphic behaviors including 
reproductive (Claro et al., 1995; Liu et al., 1997) and maternal (Numan, 1996; Numan 
and Numan, 1995) behaviors.  As such, it is considered a site of hormonal regulation. 
Progesterone, estrogen, and androgen receptors are all represented across sexes in the 
rodent BNST (Auger and de Vries, 2002; Laflamme et al., 1998; Roselli, 1991) with 
equal levels of estrogen and progesterone receptors in male and female rats and a greater 
number of androgen receptors in males (Roselli, 1991).  Immunostaining also suggests 
the presence of ALLO in this region (Saalmann et al., 2007).  Additionally, the BNST-
OV and BNST-FU of the anterior BNST are rich with CRF neurons (Phelix and Paull, 
1990), which may exert an anxiogenic influence (Daniel and Rainnie, 2016; Lee and 
Davis, 1997).  Lastly, the BNST has direct projections to CRH containing neurons in the 
paraventricular nucleus, situating it to play a major role in regulation of HPA response to 
stress (Dong et al., 2001b; Dong and Swanson, 2006).  Many projections from the BNST 
to the PVN are GABAergic, suggesting some nuclei may inhibit the stress response 
(Cullinan et al., 1993), whereas others, particularly in the ventral BNST may activate the 
PVN via CRH projecting or glutamatergic neurons (Choi et al., 2007).  Given the 
neuroendocrine properties of the BNST and its role in contextual fear, it is poised to be a 
key locus of action in mediating sex differences seen in fear and anxiety. 
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State Dependence: A Potential Mechanism of Hormone Action 
 Another possible role for hormones in mediating fear memories is through state-
dependent effects.  Here, memories are more robust when recalled in the same state in 
which they were learned (Overton, 1991).  This raises the question if hormones create 
interoceptive context cues in addition to exteroceptive context cues such as lighting, 
odors, and physical boundaries.  Little research has explored the state-dependent effects 
of hormones, however exogenous progesterone administration following ovariectomy 
produced state-dependent effects in passive avoidance whereas naturally cycling 
hormones did not (Ebner et al., 1981).  The interaction of hormone states during learning 
and testing may be critical to understanding its role.  Contextual fear is sensitive to 
exteroceptive context shifts and therefore may also be subject to interoceptive context 
shifts as well.    
 
Specific Aims 
 The central goal of this dissertation is to explore the role of ALLO in mediating 
sex differences in fear behavior via its actions in the BNST.  Following fear conditioning 
in rodents, male rats display enhanced contextual fear in comparison to females.  ALLO, 
which binds to GABAA receptors, has pronounced anxiolytic effects on a variety of 
behaviors, including contextual fear.  Females have higher circulating levels of ALLO 
compared to males through its conversion from progesterone.  The BNST may be a locus 
of ALLO action given its important role in contextual fear and hormonal modulation.  In 
Chapter 2, to test the hypothesis that ALLO modulates contextual fear via the BNST, we 
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injected ALLO into the BNST of male rats and blocked the synthesis or binding of 
ALLO in the BNST of female rats prior to testing for contextual fear or fear to a discrete 
stimulus.  This reversed the normal pattern of behavior in which males had reduced 
contextual fear and females had increased contextual fear.  As expected, neither 
manipulation affected cued fear.  The experimental design in these studies did not 
account for the possible role of state-dependent effects.  Thus, in Chapter 3, we explored 
the role of ALLO in producing state-dependent effects via the BNST or the BLA.  
Surprisingly, ALLO resulted in state-dependent effects on contextual fear when 
administered to the BNST of male rats.  Consistent with prior literature, intra-BLA 
ALLO did not confer state-dependent effects.  Because this neurosteroid produced state-
dependent effects in males, in Chapter 4, we sought to find out if progesterone, the 
precursor to ALLO, is associated with state-dependent effects in females.  First, we used 
naturally cycling female rats and explored the role of the BNST on state-dependent 
contextual fear by measuring neuronal activation, as assessed by c-fos.  Secondly, we 
used an OVX model with progesterone replacement to explore possible state-dependent 
effects on both contextual and cued fear.  Interestingly, naturally cycling progesterone 
levels results in asymmetrical state-dependent contextual fear, however, this did not 
appear to match c-fos patterns in the BNST.  The OVX model, however, produced state-
dependent fear to cued stimuli but not context.  Together, these findings suggest 
hormones and their metabolites can confer state-dependent effects on fear learning; not 
only is hormonal state either during training or during testing important, but the 
concordance between the two states matters.  
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CHAPTER II 
ALLOPREGNANOLONE IN THE BED NUCLEUS OF THE STRIA 
TERMINALIS MODULATES CONTEXTUAL FEAR IN RATS*  
 
Overview 
Trauma- and stress-related disorders are among the most common types of 
mental illness affecting the U.S. population. For many of these disorders, there is a 
striking sex difference in lifetime prevalence; for instance, women are twice as likely as 
men to be affected by posttraumatic stress disorder (PTSD). Gonadal steroids and their 
metabolites have been implicated in sex differences in fear and anxiety. One example, 
allopregnanolone (ALLO), is a neuroactive metabolite of progesterone that allosterically 
enhances GABAA receptor activity and has anxiolytic effects. Like other ovarian 
hormones, it not only occurs at different levels in males and females but also fluctuates 
over the female reproductive cycle. One brain structure that may be involved in 
neuroactive steroid regulation of fear and anxiety is the bed nucleus of the stria 
terminalis (BNST). To explore this question, we examined the consequences of 
augmenting or reducing ALLO activity in the BNST on the expression of Pavlovian fear 
conditioning in rats. In Experiment 1, intra-BNST infusions of ALLO in male rats 
suppressed freezing behavior (a fear response) to the conditioned context, but did not 
                                                
*   Reprinted with permission from: Nagaya, N., Acca, G. M., and Maren, S. (2015). 
Allopregnanolone in the bed nucleus of the stria terminalis modulates contextual fear 
in rats. Front Behav Neurosci 9, 205. Copyright 2015 Nagaya, Acca and Maren.  
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influence freezing to a discrete tone conditioned stimulus (CS). In Experiment 2, intra-
BNST infusion of either finasteride (FIN), an inhibitor of ALLO synthesis, or 17-
phenyl-(3α,5α)-androst-16-en-3-ol, an ALLO antagonist, in female rats enhanced 
contextual freezing; neither treatment affected freezing to the tone CS. These findings 
support a role for ALLO in modulating contextual fear via the BNST and suggest that 
sex differences in fear and anxiety could arise from differential steroid regulation of 
BNST function. The susceptibility of women to disorders such as PTSD may be linked 
to cyclic declines in neuroactive steroid activity within fear circuitry. 
 
Introduction 
 In the U.S., the lifetime prevalence of trauma- and stress-related disorders is 60% 
greater for women compared to men (Kessler et al., 2005a).  Indeed, posttraumatic stress 
disorder (PTSD) is twice as likely to occur in women. Sex differences in fear and 
anxiety have also been reported in non-human species. One well-established behavioral 
paradigm that models aspects of PTSD, Pavlovian fear conditioning, has revealed sex 
differences in rodents (Aguilar et al., 2003; Barker and Galea, 2010; Chang et al., 2009; 
Daviu et al., 2014; Gresack et al., 2009; Kudo et al., 2004; Maren et al., 1994; Markus 
and Zecevic, 1997; Wiltgen et al., 2001) as well as in humans (Grillon, 2008; Lebron-
Milad et al., 2012; Milad et al., 2006).  In this procedure, a neutral conditioned stimulus 
(CS, tone) that has been paired with an aversive unconditioned stimulus (US, footshock) 
comes to elicit conditioned fear responses, including freezing, increases in acoustic 
startle, and changes in heart rate and blood pressure (Fanselow and Poulos, 2005; 
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LeDoux, 2000; Maren, 2001).  After fear conditioning, male and female rats show a 
dramatic sex difference in levels of contextual freezing: females express significantly 
lower levels of freezing in the conditioning context compared to males (Barker and 
Galea, 2010; Maren et al., 1994; Markus and Zecevic, 1997).  Interestingly, males and 
females exhibit similar levels of freezing during conditioning and during the expression 
of fear to the discrete CS (Barker and Galea, 2010; Maren et al., 1994; Markus and 
Zecevic, 1997).   
 One potential neural substrate for this sex difference in contextual fear is the bed 
nucleus of the stria terminalis (BNST).  The BNST receives input from multiple limbic 
structures involved in emotional processing and sends output directly to the hub of the 
hypothalamic-pituitary-axis, the paraventricular nucleus of the hypothalamus (Crestani 
et al., 2013).  BNST lesions or inactivation selectively impair freezing to shock-
associated contexts, but not auditory CSs (Hammack et al., 2004; Resstel et al., 2008; 
Sullivan et al., 2004; Zimmerman and Maren, 2011).  In addition, BNST inactivation 
reduces light- (Walker and Davis, 1997) and corticotropin-releasing hormone (CRH)-
enhanced (Lee and Davis, 1997) startle, two forms of startle potentiation argued to 
reflect contextual fear.  BNST lesions also reduce fear to long-duration auditory CSs that 
mimic the temporal properties of contextual stimuli (Waddell et al., 2006).  Moreover, 
recent optogenetic approaches have shown that discrete neural circuits within the BNST 
are involved in regulating responses to aversive contexts (Jennings et al., 2013; Kim et 
al., 2013).  Collectively, these data suggest that the BNST is central for the expression of 
conditional fear responses, including freezing, to aversive contexts.   
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 Given its role in reproductive (Claro et al., 1995; Liu et al., 1997) and maternal 
(Numan, 1996; Numan and Numan, 1995) behaviors, the BNST is a prime site for 
hormonal modulation. BNST neurons have receptors for estrogen (Laflamme et al., 
1998), progesterone (Auger and de Vries, 2002), and androgens; levels of estrogen and 
progesterone receptors are similar between male and female rats whereas levels of 
androgen receptors are greater in males (Roselli, 1991). Indeed, hormonal modulation of 
BNST activity in fear conditioning has been implicated by studies of intact cycling 
females and ovariectomized females treated with gonadal steroids. For example, natural 
fluctuations in ovarian steroids across the estrous cycle are associated with differences in 
the expression of contextual fear such that rats in proestrus, when progesterone and 
estradiol levels are highest, show the lowest level of fear compared to males and females 
in estrus (Markus and Zecevic, 1997). Moreover, systemic administration of either 
progesterone or its neuroactive metabolite, allopregnanolone (ALLO), impairs CRH-
enhanced increases in acoustic startle, a form of startle that is mediated by the BNST 
(Toufexis et al., 2004). A potent allosteric potentiator of GABAA receptors (Majewska et 
al., 1986), ALLO has been linked to reduced anxiety in a variety of other behavioral 
paradigms in which female rodents appear less anxious than males (Frye et al., 2000; 
Hughes et al., 2004), including the elevated plus maze (Bitran et al., 1991), the defensive 
burying test (Picazo and Fernandez-Guasti, 1995), the light/dark transition test (Wieland 
et al., 1991), and the open field test (Wieland et al., 1991). Although ALLO can be 
synthesized within the gonads, adrenal glands, and brains of both male and female rats, it 
is found in higher concentrations in female brains and plasma (Corpéchot et al., 1993). 
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In females, ALLO levels in whole brain and plasma are 8- to 10-fold higher than in 
males (Cheney et al., 1995; Corpéchot et al., 1993; Purdy et al., 1990). 
Collectively, this work suggests that ALLO may regulate fear and anxiety by 
modulating neuronal activity in the BNST. To explore this question, we assessed 
whether augmenting ALLO activity in the BNST of male rats would decrease contextual 
freezing (Experiment 1) and, conversely, whether reduction of ALLO activity in the 
BNST of female rats would increase contextual freezing (Experiment 2). Males received 
intra-BNST infusions of ALLO whereas females received infusions of either an ALLO 
synthesis inhibitor, finasteride (FIN; Finn et al., 2006), or a selective antagonist, 17-
phenyl-(3α,5α)-androst-16-en-3-ol (17-PA; Mennerick et al., 2004; Kelley et al., 2007). 
Importantly, this set of experiments examines whether hypothesized sex differences in 
endogenous intra-BNST ALLO (i.e., low endogenous ALLO activity in males and high 
endogenous ALLO activity in females) contribute to the contextual fear phenotype in 
each sex. We now show that manipulations of ALLO activity within the BNST affect the 
expression of contextual fear in both male and female rats, a finding that supports 
neuroactive steroid modulation of the BNST in fear and anxiety. 
 
 
Materials and Methods 
Animals 
Male and female Long-Evans rats (200–224 g; Blue Spruce) were obtained from 
a commercial supplier (Harlan Laboratories, Indianapolis, IN, USA). At the time of 
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arrival, rats were individually housed in clear plastic cages; males and females were kept 
in separate rooms. Lights were maintained on a 14:10 h light:dark cycle (lights on at 
7:00 A.M.) with access to food and water ad libitum. Upon arrival, each rat was handled 
for 20 s each day for five consecutive days to acclimate to the experimenter. All 
experiments were carried out in accordance with guidelines approved by the Institutional 
Animal Care and Use Committees at Texas A&M University. 
 
Behavioral Apparatus 
All behavioral procedures occurred in eight identical observation chambers (30 × 
24 × 21 cm; Med Associates, St. Albans, VT, USA) composed of aluminum sidewalls 
and Plexiglas ceiling, rear wall, and front door. One sidewall contained a speaker for CS 
delivery and the other contained an incandescent house light. Chamber floors consisted 
of 19 stainless steel rods (4 mm in diameter) spaced 1.5 cm apart (center to center) for 
footshock US delivery. The rods were wired to a shock source and solid-state grid 
scrambler (Med Associates). Beneath the rods was a removable stainless steel tray. In 
addition, each chamber was positioned in a sound-attenuating cabinet equipped with a 
ventilation fan to provide background noise (65 dB). 
The behavioral procedures were conducted in two distinct contexts. For “context 
A” (conditioning and context test), the chambers were cleaned with 1% acetic acid; the 
pans beneath the floors were also rinsed in acetic acid. The house lights (15 W) in the 
chambers were lit and the cabinet doors were left open. White fluorescent room lights, 
the computer monitor, and cabinet fans were on. Animals were transported to and from 
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the vivarium in white plastic boxes. For “context B” (tone test), the chambers were 
cleaned with 1% ammonium hydroxide. The house lights were turned off and the cabinet 
doors were closed. Red fluorescent lights illuminated the room, the computer monitor 
was turned off, and the cabinet fans were on. Animals were transported to and from the 
vivarium in black plastic boxes. 
Locomotor activity was measured by recording the displacement of the load cell 
platform located underneath each chamber (Maren, 1998). Prior to the experiment, each 
load cell amplifier was calibrated to a fixed chamber displacement with the output of 
each amplifier set to a specific gain to detect immobility. The output of the load cell 
amplifier was digitized such that one observation every 200 ms for each rat was recorded 
via the Threshold Activity software (Med Associates). Freezing behavior was derived 
from the locomotor activity as previously described (Maren, 1998). 
 
Surgery 
Male rats were anesthetized with ketamine (100 mg/kg body weight; i.p.) and 
xylazine (10 mg/kg body weight; i.p.) and treated with atropine sulfate (0.04 mg/kg body 
weight, i.p.). Female rats were anesthetized with ketamine (60 mg/kg body weight; i.p.) 
and xylazine (8 mg/kg body weight; i.p.) and treated with atropine sulfate (0.04 mg/kg 
body weight; i.p.). After shaving the top of the head, each rat was secured in a 
stereotaxic apparatus (David Kopf Instruments, Tujunga, CA, USA). The scalp was 
incised and retracted. Head position was adjusted to align lambda and bregma in the 
same horizontal plane. Small burr holes (1 mm in diameter) were drilled bilaterally into 
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the skull for placement of guide cannulae (stainless steel, 26-gauge, 9 mm below 
pedestal; Plastics One, Roanoke, VA, USA) directed towards the BNST (0.0 mm AP and 
2.7 mm ML relative to bregma, −6.9 mm DV from dura at a 10° angle from vertical 
towards the midline). In addition, three burr holes were drilled for the placement of 
anchoring screws. After implantation of guide cannulae, dental acrylic was applied to 
affix the cannulae to the skull. After surgery, dummy cannulae (33-gauge, 9 mm with 1-
mm projection; Plastics One) were inserted into the guide cannulae. Rats were allowed 
to recover for 1 week before behavioral procedures. To habituate the animals to the 
infusion procedures, rats were individually transported in white 5-gal buckets lined with 
bedding to the infusion room (within the vivarium) and received dummy changes on two 
separate days during the recovery period. 
 
Vaginal Smears 
Vaginal smears were obtained from all female rats for at least eight consecutive 
days to ensure normal cycling; estrous cycle phase was not used as a variable in the 
analysis due to sample size. To track estrous cycle phase, vaginal smears were taken 
daily with cotton swabs moistened with distilled water between 8:00 and 10:00 A.M. 
starting the day of surgery and continuing throughout the behavioral procedures 
(allowing for at least 1 h between smears and behavior). Cells were visualized under a 
light microscope at 100× and characterized according to Goldman et al. (2007). One rat 
with an irregular cycle was excluded from the analysis. 
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Drugs 
All drugs were prepared in a 30% (w/v) solution of the complexing agent 
hydroxypropyl-β-cyclodextrin (VEH; Sigma-Aldrich, St. Louis, MO, USA) in purified 
water. Allopregnanolone or (3α,5α)-3-hydroxy-pregnan-20-one (ALLO; R&D Systems, 
Minneapolis, MN, USA) was solubilized in VEH (8 mg/ml). The 5α-reductase inhibitor 
commonly known as finasteride, (5α,17β)-N-(1,1-dimethylethyl)-3-oxo-4-azaandrost-1-
ene-17-carboxamide (FIN; Sigma-Aldrich), was solubilized in VEH (10 mg/ml). The 
steroid antagonist, 17-phenyl-(3α,5α)-androst-16-en-3-ol (17-PA; R&D Systems) was 
solubilized in VEH (3.5 mg/ml). Infusions were made with 10-µl Hamilton syringes 
mounted into an infusion pump (KD Scientific, Hollistan, MA, USA) and connected to 
internal cannulae (33-gauge, 9 mm with 1-mm projection; Plastics One) with either 
polyethylene tubing (PE-20, Braintree Scientific, Braintree, MA, USA) for VEH or 
polytetrafluoroethylene tubing (PTFE; 28-gauge, SAI Infusion Technologies, Lake Villa, 
IL, USA) for drugs. PTFE tubing was used to minimize drug loss due to nonspecific 
binding. 
 
Procedures 
Experiment 1: effects of ALLO on the expression of contextual and cued fear in male rats 
For the ALLO study, 31 male Long-Evans rats were housed and cannulated as 
described above. On Day 1, rats were transported to the laboratory and placed in the 
conditioning chambers (context A) for training. After a 3-min baseline period, rats were 
presented with five tone (CS; 10 s, 80 dB, 2 kHz)-shock (US; 2 s, 1 mA) pairings in 
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which the tone was immediately followed by the shock. There was a 1-min inter-trial 
interval (ITI) between each tone-shock pairing followed by a 1-min wait period after the 
final shock. On Day 2, 24 h later, squads of 4 rats were transported to the infusion room 
in white 5-gal buckets lined with bedding. Rats received bilateral intra-BNST infusions 
(0.25 µl at 0.25 µl/min) of either VEH (n = 15) or ALLO (2 µg/side; n = 16). The dosage 
and timing of ALLO infusions were based on previous reports of behavioral effects 
resulting from intracranial infusions (Akwa et al., 1999; Bitran et al., 1991; Engin and 
Treit, 2007); BNST infusion volumes were based on previous work from our laboratory 
(Zimmerman and Maren, 2011). After the 1-min infusion, internal cannulae were left in 
place for 2 min to allow for drug diffusion and then replaced with clean dummy 
cannulae. Context testing began ten minutes after the start of infusions. Rats were placed 
in the conditioning chambers (context A) for a 10-min context test in which no tones or 
shocks were delivered. On Day 3, rats were infused in the same manner with the same 
drug as on Day 2 and, at 10 min after the start of infusions, were placed in a novel 
context (context B) for a tone test. The tone test consisted of a 3-min baseline period 
followed by four tone (CS; 10 s, 80 dB, 2 kHz) presentations with a 1-min ITI and a 1-
min wait period after the last tone. The conditioning and testing procedures (including 
the order of context and tone tests) were patterned after the experimental designs used in 
many of our studies (Maren, 1998; 1999b; Maren et al., 1997; Zimmerman and Maren, 
2011), including work revealing sex differences in the expression of contextual fear 
(Maren et al., 1994). 
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Experiment 2: effects of FIN and 17-PA on the expression of contextual and cued fear in 
female rats 
Seventy-six female Long-Evans rats were housed and cannulated as described 
above. On Day 1, rats were transported to the laboratory, placed in the conditioning 
chambers (context A) and trained in the same manner as in Experiment 1. On Day 2, 
squads of 8 rats were transported to the infusion room in white 5-gal buckets lined with 
bedding. Rats received bilateral intra-BNST infusions (0.25 µl at 0.25 µl/min) of VEH, 
FIN (2.5 µg/side), or 17-PA (0.875 µg/side). The doses of FIN and 17-PA were based on 
previous reports (Frye and Vongher, 2001; Frye and Walf, 2002; Kelley et al., 2007; 
Rhodes and Frye, 2001; Svensson et al., 2013; Walf et al., 2006). After the 1-min 
infusion, internal cannulae were left in place for 2 min to allow for drug diffusion and 
then replaced with clean dummy cannulae. Animals receiving FIN infusions (and a 
subset of VEH controls) were returned to their home cages for 2 h prior to retrieval 
testing to allow sufficient time for 5α-reductase inhibition (Frye and Walf, 2002; Rhodes 
and Frye, 2001; Walf et al., 2006). Rats in the 17-PA group (and a subset of VEH 
controls) were tested 10 min after their infusions (Svensson et al., 2013). For the context 
testing, rats were transported to the conditioning chambers (context A) for a 10-min 
context test as described in Experiment 1. On Day 3, rats were infused with the same 
drug as on Day 2 and were transported to a novel context (context B) for a tone test as 
described in Experiment 1. One rat from the FIN group was excluded due to acyclicity 
and a squad of rats (4 VEH and 4 17-PA) was excluded due to an equipment 
malfunction. Data from VEH controls for the FIN and 17-PA groups were collapsed for 
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analysis as they did not differ. This left group sizes of: VEH (n = 26), FIN (n = 15), and 
17-PA (n = 12). 
 
Histology 
After behavioral testing, all rats were overdosed with pentobarbital (100 mg/kg) 
and transcardially perfused with 0.9% saline followed by 10% formalin. Brains were 
rapidly dissected and post-fixed in 10% formalin for 24 h before transfer to a 30% 
sucrose-formalin solution. Brains were sectioned at 40 µm on a cryostat at a constant 
temperature of −20°C and mounted on subbed slides with 70% ethanol. Sections were 
stained with 0.25% thionin to visualize cannulae placements within the BNST. 
 
Data Analysis 
 In all experiments, the percentage of freezing behavior was averaged across 1-
min blocks in each behavioral session (the 10-s CS periods were excluded from the 
analysis of the conditioning and tone test sessions) and analyzed using analysis of 
variance (ANOVA). We hypothesized that across the context tests, ALLO would reduce 
freezing in males and FIN and 17-PA would increase freezing in females. Therefore, a 
priori planned comparisons using Fisher’s PLSD test were computed after significant 
effects in the ANOVA. All data are represented as means ± SEMs. 
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Results 
Intra-BNST ALLO Infusion and Contextual Fear in Male Rats 
Histology 
Of 31 male rats receiving cannulae, nine were excluded because their cannulae 
were not centered in the BNST. This yielded the following group sizes: VEH (n = 9) and 
ALLO (n = 13). As shown in Figure 2A, the majority of cannula placements were 
centered at 0.26 mm caudal to bregma, although placements both rostral and caudal to 
that level were similarly represented. 
Behavior 
Acquisition of fear conditioning did not differ between male groups assigned to 
receive infusions of VEH or ALLO (Figure 3A). Levels of freezing were low (<10%) 
prior to the start of training and increased across the five training trials similarly for all 
animals. A repeated measures ANOVA with a between-subjects variable of drug group 
(VEH or ALLO) showed a significant main effect of trial number (TRIAL) on the level 
of freezing expressed (F(5,100) = 18.0, p < 0.0001) but neither the main effect of drug 
group (F(1,20) = 1.88, p = 0.19) nor the interaction between drug group and trial number 
(F(5,100) = 0.30, p = 0.91) was found to be significant. Thus, all male rats acquired 
conditioned fear at similar rates and levels prior to their drug manipulations. 
Intra-BNST ALLO infusions 10 min prior to testing resulted in a decreased level 
of freezing to the conditioned context for male rats (Figure 3B). A repeated measures 
ANOVA with a between-subjects variable of drug group (VEH or ALLO) showed that 
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Figure 2 Schematic coronal sections showing cannula placements in the bed nucleus 
of the stria terminalis (BNST).  
Cannula placements are indicated for infusions of vehicle (VEH), allopregnanolone (ALLO), 
finasteride (FIN), and 17-phenyl-(3α,5α)-androst-16-en-3-ol (17-PA). Representative thionin-
stained sections are shown below each set. (A) Infusion sites for VEH (red circles) and ALLO 
(blue circles) in male rats with photomicrograph of a representative section. (B) Infusion sites for 
VEH (red circles), FIN (blue circles), and 17-PA (green circles) in female rats with 
photomicrograph of a representative section. Coronal brain section images adapted from 
Swanson (2003). 
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Figure 3 Conditioned freezing in male rats receiving pre-test infusions of ALLO 
into the BNST.  
(A) Mean percentage of freezing (±SEM) during the five-trial training session (data are shown 
with a 3-min pre-trial period followed by five tone-shock pairings). Freezing was quantified 
before the first conditioning trial (baseline, BL) and during the 1-min period after each 
conditioning trial. (B) Mean percentage of freezing (±SEM) to context over 10 min 1 day after 
training. (C) Mean percentage of freezing (± SEM) to four auditory conditioned stimulus (CS) 
presentations in a novel context 2 days after training. Freezing was quantified before the first 
tone trial (baseline, BL) and during the 1-min period after each tone trial. *p < 0.05 ALLO vs. 
VEH. 
 
 
 
intra-BNST infusion of ALLO suppressed freezing throughout the 10-min context test. 
The analysis revealed significant main effects of drug group (F(1,20) = 5.22, p < 0.05) and 
time (min 1–10; F(9,180) = 2.08, p < 0.05). In addition, there was a significant interaction 
between drug group and time (F(9,180) = 1.99, p < 0.05). Planned comparisons (p < 0.05) 
of the average freezing during each minute of the context test revealed that ALLO 
significantly reduced freezing during minutes 2–5 and minute 7 of the test (Figure 3B). 
These data indicate that acute ALLO administration in the BNST suppressed the 
expression of contextual fear in male rats. 
By contrast, pre-test infusion of ALLO into the BNST did not affect conditional 
freezing during the tone test (Figure 3C). A repeated measures ANOVA with a between-
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subjects variable of drug group (VEH or ALLO) and a within-subject variable of trial 
number (TRIAL) revealed a main effect of trial (F(4,80) = 16.9, p < 0.0001), but there was 
neither a significant main effect of drug group (F(1,20) = 0.97, p = 0.34) nor an interaction 
between drug group and trial (F(4,80) = 0.50, p = 0.73). These data indicate that acute 
ALLO administration in the BNST produces a selective reduction in contextual freezing 
in male rats. 
 
Intra-BNST Infusion of FIN or 17-PA and Expression of Contextual Fear in 
Female Rats 
Histology 
Of the 67 cycling female rats, 14 were excluded because their cannulae either 
missed the target or were not patent (resulting in a unilateral infusion). This yielded the 
following group sizes: VEH (n = 26), FIN (n = 15), and 17-PA (n = 12). As shown in 
Figure 2B, the majority of cannula placements were centered 0.26 mm caudal to bregma 
although there were many placements rostral and caudal to that level. 
Behavior 
Acquisition of fear conditioning did not differ between the females assigned to 
receive VEH, FIN, or 17-PA (Figure 4A). Levels of freezing were low prior to the start 
of training (<5%) and increased across the five training trials similarly for all animals. A 
repeated measures ANOVA with a between-subjects variable of drug group (VEH, FIN, 
or 17-PA) and a within-subject variable of trial (TRIAL) showed a main effect of trial 
(F(5,250) = 24.7, p < 0.0001). There was neither a significant main effect of group 
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(F(2,50) = 0.31, p = 0.74) nor an interaction between drug group and trial (F(10,250) = 
0.98, p = 0.46). Thus, female rats from all groups acquired conditioned fear at similar 
rates and levels prior to their drug manipulations. 
As shown in Figure 4B, intra-BNST infusions of either FIN or 17-PA prior to 
testing (2 h or 10 min, respectively) modestly, but significantly, increased levels of 
freezing to the conditioned context in female rats. A repeated measures ANOVA with a 
between-subjects variable of drug group (VEH, FIN, or 17-PA) and a within-subject 
variable of time (min 1–10) revealed a significant main effect of time (F(9,450) = 14.6, p < 
0.0001) and a significant group X time interaction (F(18,450) = 1.81, p < 0.05). There was 
no significant main effect of drug group (F(2,50) = 1.36, p = 0.27). Inspection of 
Figure 4B suggested that the significant group X time interaction in the ANOVA was 
due to increases in freezing produced by intra-BNST infusions of FIN and 17-PA in the 
early minutes of the context test. This impression was confirmed by planned 
comparisons (p < 0.05) of average freezing during each minute of the context text. These 
comparisons revealed that FIN increased freezing relative to VEH-treated rats during the 
first 2 min of the test; 17-PA increased freezing relative to VEH controls in minutes 2–4 
of the context test. These data indicate that intra-BNST infusion of an ALLO synthesis 
inhibitor (FIN) or an ALLO antagonist (17-PA) enhanced the expression of contextual 
freezing in females. 
 As shown in Figure 4C, pre-test intra-BNST infusions of either FIN or 17-PA did 
not affect freezing during the tone test. A repeated measures ANOVA with a between-
subjects variable of drug group (VEH, FIN, or 17-PA) and a within-subject variable of 
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Figure 4 Conditioned freezing in female rats receiving pre-test infusions of either 
FIN or 17-PA into the BNST.  
(A) Mean percentage of freezing (± SEM) for all females during the five-trial training session 
(data are shown with a 3-min pre-trial period followed by five tone-shock pairings). Freezing 
was quantified before the first conditioning trial (baseline, BL) and during the 1-min period after 
each conditioning trial. (B) Mean percentage of freezing (± SEM) to context over 10 min 1 day 
after training. (C) Mean percentage of freezing (± SEM) to four auditory CS presentations in a 
novel context 2 days after training. Freezing was quantified before the first tone trial (baseline, 
BL) and during the 1-min period after each tone trial. *p < 0.05 FIN vs. VEH, #p < 0.05 17-PA 
vs. VEH. 
 
 
 
trial number (TRIAL) showed a main effect of trial number (F(4,200) = 68.8, p < 0.0001). 
There was neither a significant main effect of drug group (F(2,50) = 0.09, p = 0.92) nor an 
interaction between drug group and trial number (F(8,200) = 0.44, p = 0.90). These data 
reveal that intra-BNST infusions of FIN or 17-PA produce a selective enhancement of 
contextual freezing in female rats. 
 
Discussion 
The present results reveal that manipulations of ALLO activity within the BNST 
modulate the expression of conditioned contextual fear in rats. Consistent with our 
hypothesis, endogenous ALLO activity in males and females appears to contribute to the 
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contextual fear phenotype in each sex. For males, in which brain ALLO levels are 
relatively low, augmenting BNST ALLO levels suppressed the expression of contextual 
freezing. In contrast, for females, in which brain ALLO levels are relatively high, 
reducing intra-BNST ALLO activity enhanced the expression of contextual freezing. 
The effects we observed were not likely due to nonspecific sensorimotor effects of the 
BNST drug manipulations insofar as freezing to the auditory CS was unaffected by all 
treatments. Together, our results suggest that ALLO in the BNST may be a critical 
modulator of fear behavior in both male and female rats. 
By utilizing ALLO infusions into the brain, our findings extend previous work 
linking circulating gonadal steroid levels to contextual fear in female rats (Markus and 
Zecevic, 1997; Toufexis et al., 2004). In these studies, intact female rats that were 
conditioned and tested during proestrus, when progesterone levels are high, exhibited 
lower levels of contextual freezing compared to those trained and tested in other phases 
of the estrous cycle (Markus and Zecevic, 1997). In addition, ovariectomized female rats 
treated with systemic ALLO showed a significant reduction in CRH-enhanced but not 
fear-potentiated acoustic startle (Toufexis et al., 2004). The former is a test of 
“sustained” or contextual fear whereas the latter is a test of “phasic” or cued fear (Davis 
et al., 2010). Similar reductions have been observed in ovariectomized females treated 
either acutely or chronically with progesterone (Toufexis et al., 2004). By contrast, 
systemic treatment of ovariectomized females with medroxy-progesterone acetate, a 
synthetic steroid that binds to the progesterone receptor but is not metabolized to ALLO, 
did not affect levels of CRH-induced startle (Toufexis et al., 2004). Altogether, these 
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data suggest that the reduced levels of context-dependent fear observed in females with 
elevated circulating progesterone levels may be due to the actions of its metabolite, 
ALLO, within the BNST. 
Additional evidence supporting ALLO modulation of contextual fear can be 
found in studies of socially isolated mice. Male mice that have been socially isolated for 
three to four weeks show elevated levels of context- but not cue-specific fear (Pibiri et 
al., 2008). Interestingly, this change in conditioned fear behavior coincides with 
decreases in ALLO and 5α-reductase mRNA within components of the fear circuitry 
(medial prefrontal cortex, hippocampus, and basolateral amygdala). Group-housed mice 
showed similar increases in contextual fear following pharmacological blockade of 5α-
reductase. This work lends support to the idea that reduced 5α-reductase activity in fear 
circuits can contribute to reduced ALLO levels in brain and concomitantly elevated 
contextual fear. We cannot, however, exclude the possibility that the early effects of FIN 
on contextual freezing in females may be due to reduced levels of the GABAergic 
potentiators, (3α,5α,17β)-androstane-3, 17-diol (3α-androstanediol) and (3α,5β)-3, 21-
dihydroxypregnan-20-one (tetrahydrodeoxycorticosterone or THDOC), as 5α-reductase 
is involved in the synthesis of these compounds from 17-hydroxyandrostan-3-one 
(dihydrotestosterone or DHT) and 11-deoxycorticosterone (deoxycorticosterone or 
DOC), respectively (Reddy, 2010). 
The results of the current study are consistent with the widely held view that the 
BNST is critical for the expression of contextual fear responses (Sullivan et al., 2004; 
Zimmerman and Maren, 2011) and support a role for GABAergic synaptic transmission 
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therein. Previous work involving infusions of the GABAergic agonist, muscimol, (Fendt 
et al., 2003) and a GABA synthesis inhibitor (Sajdyk et al., 2008) has underscored the 
importance of the inhibitory neurotransmitter in regulating fear and anxiety via the 
BNST. Here we show for the first time that ALLO modulation of GABAA receptors in 
the BNST may be involved in the regulation of contextual fear. While its use in 
behavioral paradigms is quite new, 17-PA has been well-characterized by in vitro and in 
vivo studies for its selective antagonism of ALLO action at GABAA receptors (Kelley et 
al., 2007; Mennerick et al., 2004; Svensson et al., 2013). Although its antagonism of 3α-
androstanediol has not been examined, 17-PA has been shown to be ineffective against 
5β-reduced steroids, barbiturates, and benzodiazepines and only partially effective 
against THDOC (Kelley et al., 2007; Mennerick et al., 2004). Thus, the effects of the 5α-
reductase inhibitor, FIN, on contextual fear in females when considered in conjunction 
with those of 17-PA provide support for locally available ALLO acting at 
GABAA receptors within the BNST. 
Recent human studies support links between ALLO, the BNST, and 
dysfunctional anxiety. Decreased levels of ALLO in CSF have been reported in 
premenopausal women diagnosed with PTSD compared to healthy individuals although 
it was not known whether this deficiency was pre-existing (Rasmusson et al., 2006). A 
context-specific role for the BNST in conditioned fear may apply to humans. Imaging 
studies have shown that nonhuman primates with trait anxious temperament have 
increased resting metabolism in the BNST (Oler et al., 2009) and that trait anxious 
human subjects exhibit exaggerated activity in the BNST during threat monitoring 
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(Somerville et al., 2010), suggesting that “hypervigilant threat monitoring” (akin to 
contextual fear) may be a BNST-dependent process. 
Nonetheless, the rodent data present a paradox: female rats with presumably 
higher levels of circulating ALLO exhibit less contextual fear and extinguish their fear 
responses faster than males, a pattern of results that seemingly contradicts that observed 
in human females (Chang et al., 2009; Gupta et al., 2001; Maren et al., 1994). Namely, 
although women cyclically attain higher circulating levels of ALLO than men 
(Genazzani et al., 1998), they exhibit a greater susceptibility to PTSD (Kessler et al., 
2005a). One answer to this paradox may lie in the relative propensity of males and 
females to extinguish fear once it is acquired. For example, studies in both rats (Chang et 
al., 2009; Gupta et al., 2001; Milad et al., 2009; Zeidan et al., 2011) and humans (Milad 
et al., 2006; 2009; 2010) reveal that low but not high estrogen levels in females retard 
the extinction of conditioned fear below that observed in males. Deficits in fear 
extinction are widely believed to contribute to the maintenance of PTSD (Maren et al., 
2013; Pitman et al., 2012) and the regulation of fear extinction by gonadal steroids may 
be critical to increasing the vulnerability of both female rats and humans to persistent 
and pathological fear responding. Although it is not known how progesterone and its 
metabolites contribute to fear extinction, it is also possible that low levels of ALLO 
produce a resistance to extinction that contributes to enduring fear responses thought to 
underlie PTSD (Pinna, 2014). In socially isolated male mice, systemic administration of 
ganaxolone, a synthetic analog of ALLO, has been shown to facilitate extinction of 
contextual fear (Pinna and Rasmusson, 2014). Thus, cyclical variation in neuroactive 
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steroid levels in female rats and humans might promote vulnerabilities to fear extinction, 
thereby contributing to disorders such as PTSD. It should be noted that ganaxolone is 
currently in clinical trials for treatment of PTSD (NCT01339689). 
In summary, our findings suggest that ALLO within the BNST modulates 
contextual fear in both male and female rats. Although we cannot speak to the relative 
contribution of different ALLO sources (peripheral vs. brain), immunolabeling studies 
have shown high levels of cellular staining in the rat BNST by an anti-ALLO antibody 
(Cook et al., 2014; Saalmann et al., 2007), supporting the local availability of this 
progesterone metabolite. As previously suggested by systemic administration, ALLO 
promotes anxiolytic behavior in response to fear-conditioned contexts and may account 
for sex differences observed in contextual fear. In women, deficiencies or large 
variations in circulating and brain ALLO over the reproductive cycle may contribute to 
increased vulnerability for anxiety disorders such as PTSD. Further work on the cellular 
and molecular mechanisms of ALLO action in the BNST may yield insight on 
determinants of susceptibility to anxiety disorders both within and across genders and 
inform on potential avenues of pharmacological intervention. 
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CHAPTER III 
ALLOPREGNANOLONE INDUCES STATE-DEPENDENT FEAR VIA THE 
BED NUCLEUS OF THE STRIA TERMINALIS* 
 
Overview 
 Gonadal steroids and their metabolites have been shown to be important 
modulators of emotional behavior.  Allopregnanolone (ALLO), for example, is a 
metabolite of progesterone that has been linked to anxiety-related disorders such as 
posttraumatic stress disorder.  In rodents, it has been shown to reduce anxiety in a 
number of behavioral paradigms including Pavlovian fear conditioning.  We have 
recently found that expression of conditioned contextual (but not auditory) freezing in 
rats can be suppressed by infusion of ALLO into the bed nucleus of the stria terminalis 
(BNST).  To further explore the nature of this effect, we infused ALLO into the BNST 
of male rats prior to both conditioning and testing.  We found that suppression of 
contextual fear occurred when the hormone was present during either conditioning or 
testing but not during both procedures, suggesting that ALLO acts in a state-dependent 
manner within the BNST.  A shift in interoceptive context during testing for animals 
conditioned under ALLO provided further support for this mechanism of hormonal 
action on contextual fear.  Interestingly, infusions of ALLO into the basolateral 
                                                
* Reprinted with permission from: Acca, G. M., Mathew, A. S., Jin, J., Maren, S., and 
Nagaya, N. (2017). Allopregnanolone induces state-dependent fear via the bed nucleus 
of the stria terminalis. Horm Behav 89, 137–144. Copyright 2017 Elsevier Inc. 
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amygdala produced a state-independent suppression of both conditioned contextual and 
auditory freezing.  Altogether, these results suggest that ALLO can influence the 
acquisition and expression of fear memories by both state-dependent and state-
independent mechanisms. 
 
Introduction 
The importance of sex steroid hormones in anxiety-related disorders has gained 
recent support from both preclinical and clinical studies (Glover et al., 2015; Maeng and 
Milad, 2015).  Estrogen has been shown to affect different aspects of fear learning 
including acquisition of contextual fear (Barha et al., 2010), facilitation of fear extinction 
in female rats (Chang et al., 2009; Gupta et al., 2001; Milad et al., 2009) and humans 
(Milad et al., 2009; 2010; Zeidan et al., 2011) as well as modulation of fear 
generalization in male and female rats (Lynch et al., 2014; 2016).  Progesterone has 
mixed effects on fear extinction; it is facilitatory in some instances (rats; Milad et al., 
2009) and impairing in others (humans; Pineles et al., 2016).  Support for a role of 
androgens in conditioned fear has also varied across studies.  Castration with or without 
testosterone replacement had no effect on the acquisition, expression, or extinction of 
conditioned contextual fear in male rats (Anagnostaras et al., 1998).  In contrast, when 
light-enhanced startle (similar to contextual fear) and fear-enhanced startle (similar to 
cued fear) were examined in male rats, androgens were found to suppress the former but 
not the latter (Toufexis et al., 2005). 
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Modulation of conditioned fear processes may involve steroid metabolites as 
well.  Allopregnanolone (ALLO), a major metabolite of progesterone, has been 
associated with decreased levels of context-related fear (Pibiri et al., 2008; Toufexis et 
al., 2004) and its synthetic analogue, ganaxolone, has been shown to facilitate extinction 
in mice (Pinna and Rasmusson, 2014).  We have recently shown that local ALLO 
activity in the bed nucleus of the stria terminalis (BNST) modulates the expression of 
conditioned contextual fear (Nagaya et al., 2015).  In male rats, increased ALLO activity 
via local infusion suppressed context-dependent freezing whereas in female rats, 
decreased ALLO activity via pharmacological means resulted in enhanced freezing.  
Given that ALLO has been shown to be a potent allosteric potentiator of GABAA 
receptor (GABAR) currents (Majewska et al., 1986), one possible mechanism of ALLO 
action on contextual fear may involve GABARs within the BNST. 
The importance of GABARs in regulating contextual fear has been recently 
demonstrated by studies of fear acquisition and expression following intra-hippocampal 
infusion of gaboxadol (Jovasevic et al., 2015).  Interestingly, this work revealed that 
activation of extrasynaptic GABARs within the hippocampus produces state-dependent 
contextual fear.  That is, intra-hippocampal gaboxadol infusions before either fear 
conditioning or retention testing blunted the expression of contextual fear in mice.  
However, gaboxadol infusions before both conditioning and testing resulted in high 
levels of conditioned freezing—indicating a state-dependent effect of GABAR 
modulation.   ALLO shares similarities with gaboxadol in that it promotes GABAergic 
tone especially at extrasynaptic GABARs (Brown et al., 2002; Mortensen et al., 2012).  
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As such, we explored the mechanism by which ALLO affects conditioned fear by 
administering it into the BNST or the BLA prior to acquisition, expression, or both. 
 
Materials and Methods 
Subjects 
Adult male Long-Evans rats (200-224 g at arrival; Blue Spruce) were purchased 
from a commercial supplier (Envigo, Indianapolis, IN, USA).  Rats were individually 
housed in clear plastic cages and maintained on a 14:10 h light:dark cycle (lights on at 
7:00 AM) in a temperature- and humidity-controlled vivarium with unrestricted access to 
food and water.  All experiments occurred during the light phase.  Upon arrival, rats 
were handled for five consecutive days for approximately 20 s each day to acclimate to 
the experimenter.  All procedures were performed in accordance with the guidelines 
approved by the Texas A&M University Institutional Animal Care and Use Committees.   
 
Behavioral Apparatus  
All behavioral sessions occurred in eight identical observation chambers (30 x 24 
x 21 cm; Med Associates, St. Albans, VT, USA) in a single testing room.  Each chamber 
consisted of two aluminum sidewalls, a Plexiglas ceiling, rear wall, and hinged front 
door.  A speaker for delivery of the auditory conditioned stimulus (CS) was mounted on 
one sidewall and an incandescent house light (15 W) was mounted on the other.  The 
floor of each chamber consisted of 19 stainless steel rods (4 mm in diameter) spaced 1.5 
cm apart (center to center) for delivery of the footshock unconditioned stimulus (US).  
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Rods were connected to a shock source and solid-state grid scrambler (Med Associates).  
A removable stainless steel tray underneath the rods was used to manipulate contexts 
with odors.  Each chamber was situated inside a sound-attenuating cabinet equipped with 
a ventilation fan to provide background noise (65 dB). 
Behavioral procedures were conducted using two distinct contexts.  For “Context 
A”, white fluorescent room lights, cabinet fans, and house lights were all on and cabinet 
doors left open.  Each chamber was cleaned with 1% acetic acid; a small amount of 
liquid remained in the tray beneath the floor rods.   Subjects were transported to and 
from the vivarium in white plastic boxes and the computer monitor in the room was left 
on.  For “Context B”, red fluorescent room lights and cabinet fans were on whereas 
house lights were off and cabinet doors kept closed.  Each chamber was cleaned with 1% 
ammonium hydroxide; a small amount of liquid remained in the tray beneath the floor 
rods.  Subjects were transported to and from the vivarium in black plastic boxes and the 
computer monitor in the room was turned off. 
Each chamber rested on a load cell to measure locomotor activity via Threshold 
Activity Software (Med Associates).  Before the experiment, each load cell was 
calibrated to a specific displacement with the output of each amplifier set to a specific 
gain.  The results from this output were digitized at 5 Hz, such that one observation 
every 200 ms was recorded.  Freezing was only detected if the rat was immobile for, at 
minimum, 1 s.   
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Surgery 
Rats were anesthetized with isoflurane (5% induction, 2% maintenance).  The top 
of the head was shaved and the rat was secured in the stereotaxic apparatus (David Kopf 
Instruments, Tujunga, CA, USA) and given a subcutaneous injection of lidocaine before 
incision.  After incision and retraction of the scalp, the head was adjusted such that 
lambda and bregma were aligned in the same horizontal plane.  Three small holes were 
drilled for placement of anchoring screws and two small holes were drilled for bilateral 
implantation of guide cannulae (stainless steel, 26-gauge, 9 mm for the BNST, 11 mm 
for the BLA; Plastics One, Roanoke, VA, USA) attached to internal cannulae (33-gauge, 
9 or 11 mm with 1-mm projection; Plastics One) directed at the BNST (0.0 mm AP, ±2.7 
mm ML, -6.9 mm DV from dura at a 10° angle towards the midline) and BLA (-2.9 mm 
AP, ±4.9 mm ML, -7.4 mm DV from dura).  Dental acrylic was applied around the 
anchoring screws and guide cannulae.  After surgery, internal cannulae were removed 
and replaced with dummy cannulae, projecting 1 mm beyond the guide cannulae (33-
gauge; Plastics One).  Rats received one week of recovery prior to the start of behavioral 
procedures.  To habituate the animals to the infusion procedure, rats were transported in 
white, 5-gal buckets lined with bedding to the infusion room.   Rats were gently 
restrained and dummy cannulae were changed twice prior to the start of behavioral 
experiments.     
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Drugs 
Allopregnanolone or (3α,5α)-3-hydroxy-pregnan-20-one (ALLO; R&D Systems, 
Minneapolis, MN, USA) was solubilized (8 mg/ml) in 30% (w/v) hydroxypropyl-β-
cyclodextrin in purified water (VEH; Sigma-Aldrich, St. Louis, MO, USA).   
 
Infusions 
All rats were individually transported from their home cages to the infusion room 
in 5-gal white buckets and dummy cannulae were removed.  Infusions were made with 
internal cannulae secured to either polyethylene tubing (PE-20, Braintree Scientific, 
Braintree, MA, USA) for VEH or polytetrafluoroethylene tubing (PTFE; 28-gauge, SAI 
Infusion Technologies, Lake Villa, IL, USA) for ALLO.  Tubing was connected to 10-µl 
Hamilton syringes mounted on an infusion pump (KD Scientific, Hollistan, MA, USA).  
Bilateral infusions of VEH and ALLO were made at a rate 0.25 µl/min for a total volume 
of 0.25 µl in the BNST and 0.3 µl in the BLA.  Internal cannulae were left in place for a 
2 min post-infusion period to allow for drug diffusion.  Fresh dummy cannulae were 
then inserted and rats remained in buckets until 10 min post-infusion after which they 
were transported to the testing rooms in plastic boxes for behavior.  Previous work in our 
laboratory has found reliable effects of ALLO at this dosage without producing sedation 
(Nagaya et al., 2015). 
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Experiment 1: effects of intra-BNST ALLO on the acquisition and expression of 
contextual and cued fear 
Rats were housed and implanted with cannulae targeting the BNST as described 
above.  The behavioral experiment followed a 2 X 2 factorial design consisting of four 
different groups: V/V, V/A, A/A, and A/V (V= VEH, A=ALLO; the first letter signifies 
drug state on conditioning day and the second letter signifies drug state on testing days).  
On Day 1, rats were transported to the infusion room and received bilateral infusions of 
VEH or ALLO (2 µg/side) targeting the BNST.  Ten minutes following the start of the 
infusion, rats were transported in white plastic boxes to the observation chambers for 
conditioning (Context A).  Conditioning consisted of a 3-min baseline period, followed 
by five tone (CS; 10 s, 80 dB, 2kHz) -shock (US; 2 s, 1 mA) pairings in which the tone 
immediately followed the shock.  A 1-min inter-trial interval (ITI) separated each tone-
shock pairing.  Following the last conditioning trial, there was a 1-min waiting period 
after which rats were returned to their home cages.  Contextual and cued fear testing 
occurred over Days 2 and 3.  Half of the animals were counterbalanced for order of 
context and cued tests.  As previously shown (Nagaya et al., 2015), the suppressive 
effect of intra-BNST ALLO on freezing was limited to context exposure.  Therefore, the 
remaining half of the animals only received context tests.  On Day 2, rats were infused in 
the same manner as on Day 1 with either the same drug or a different drug.  Ten minutes 
after infusion, rats were transported to either the conditioning context (Context A) for 
context testing or a novel context (Context B) for cued fear testing.  Context testing 
consisted of a 10-min test with no tones or shocks given.  Cued fear testing consisted of 
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a 3-min baseline period followed by four CS presentations with a 1-min ITI and a 1-min 
period after the final tone.  On Day 3, rats were infused in the same manner and with the 
same drug as on Day 2.  After 10 min, rats were transported to the testing room for either 
context or cued fear testing. 
Experiment 2:  effects of intra-BLA ALLO on the acquisition and expression of 
contextual and cued fear 
Rats were housed and implanted with cannulae targeting the BLA as described 
above.  Similar to Experiment 1, this experiment followed a 2 X 2 factorial design 
yielding groups conditioned under VEH or ALLO (2.4 µg/side) and tested in either the 
same or different drug state.  All subjects were tested for both context and cued fear with 
the order of testing counterbalanced across groups.  On Day 1, rats were infused with 
either VEH or ALLO and then conditioned in Context A.  On Days 2 and 3, rats were 
given either context (Context A) or cued fear (Context B) testing.  On Day 2, rats were 
infused with either the same or different drug as on conditioning day.  On Day 3, rats 
received the same drug as on Day 2. 
Experiment 3: contribution of intra-BNST ALLO to interoceptive and exteroceptive 
states 
Subjects were housed and cannulated as described above.  Unlike Experiments 1 
and 2, this experiment involved animals that were all conditioned under the same context 
(Context A) and drug state (ALLO) and then tested in context and drug states that were 
either the same as those at conditioning or different, yielding the following groups with 
different shift conditions for context testing:  None (no shift), Context (context shift 
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only), Drug (drug shift only), and Context & drug (context and drug shift).  On Day 1, 
rats were transported to the infusion room and received bilateral infusions of ALLO (2 
µg/side) into the BNST in the same manner as previously described.  Ten minutes after 
the infusion, rats were transported to the conditioning room (Context A) and trained 
under the same conditions as in Experiment 1.  On Day 2, rats were infused with either 
VEH or ALLO.  After 10 min, rats were placed in either the conditioning context 
(Context A) or a novel context (Context B).  As in the previous experiments, context 
testing consisted of a 10-min test with no tone or shock presentations.  Subjects were not 
tested for cued fear. 
 
Histology 
After all behavioral testing, animals were overdosed with sodium pentobarbital 
(100 mg/kg) and perfused transcardially with 0.9% saline and 10% formalin.  Brains 
were rapidly extracted and post-fixed for 24 h in 10% formalin at 4 °C before being 
transferred to a 30% sucrose-formalin solution.  Using a cryostat set at -20 °C, brains 
were sectioned at 40 µm and mounted onto gelatin-subbed slides with 70% ethanol.  
Sections were stained with 0.25% thionin and imaged at 10X (Leica Microsystems, 
Buffalo Grove, IL) to ensure proper cannula placement for each experiment. 
 
Data Analysis 
The percentage of freezing behavior during conditioning was averaged across the 
3-min pre-CS baseline period, the 1-min ITI for each trial, and the final 1-min post-trial 
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period.  For context tests, mean of percentage freezing was averaged across the entire 
10-min period.  For cued tests, freezing was computed as the mean of percentage 
freezing during the 1-min ITI for each trial and the final 1-min post-trial period.  All data 
were analyzed with repeated or factorial analysis of variance (ANOVA) and represented 
as means ± SEMs (α = 0.05).  In the case of significant F ratios, Fisher’s protected least 
significant difference (PLSD) post hoc comparisons were performed.  Effect size 
estimates were calculated using η2 for ANOVAs (ratio of effect variance to total 
variance) and Cohen’s d for pairwise comparisons 
(http://www.campbellcollaboration.org/escalc/html/EffectSizeCalculator-SMD1.php). 
 
Results 
Effects of intra-BNST ALLO on the acquisition and expression of contextual and 
cued fear 
Histology 
A photomicrograph of a thionin-stained brain section shows the representative 
bilateral placement of cannulae targeted to the anterior BNST (Figure 5A).  Figure 5B 
depicts the cannula placements for all subjects included in Experiments 1 and 3.  For 
Experiment 1, 64 rats were implanted; nine were excluded due to improper cannula 
placement.  Cannula damage during experimental procedures resulted in the exclusion of 
two subjects and an additional four did not survive the study.  This yielded the following 
group sizes:  V/V (n = 12), A/A (n = 11), A/V (n = 14), and V/A (n = 12).  All subjects 
included had tip placements localized to the anterior BNST, both dorsal and ventral to 
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the anterior commissure.  Cannula placements for Experiment 1 were distributed from 
0.00 to -0.46 mm relative to bregma, with the majority occurring between -0.11 and -
0.26 mm. 
Behavior 
Groups receiving VEH or ALLO prior to acquisition started with low baseline 
levels of freezing which then increased during conditioning trials (Figure 5C).  
Throughout conditioning, ALLO-treated subjects exhibited increased levels of freezing 
relative to VEH-treated animals.  A repeated measures ANOVA showed a significant 
main effect of drug state (F(1,47)  =  8.1, p < 0.01, η2 = 0.147) and trial number (F(5,235) =  
48, p<0.0001, η2 = 0.496) on freezing.  There was no significant interaction between 
drug state and trial number (F(5,235) = 1.3, p = 0.26, η2 = 0.014).  These data indicate that 
pre-training infusions of ALLO into the BNST facilitate acquisition of fear conditioning.  
Context testing (Figure 5D) revealed elevated levels of freezing in subjects 
trained and tested in the same drug state (V/V and A/A) and reduced levels of freezing in 
subjects trained and tested in different drug states (V/A and A/V).  A factorial ANOVA 
showed no significant main effect of training state (F(1,45) = 0.60,  p = 0.44, η2 = 0.001) 
or testing state (F(1,45) = 0.16,  p = 0.69, η2 = 0.003) on context-specific freezing.  There 
was, however, a significant interaction between training and testing states (F(1,45) = 15, p 
< 0.001, η2 = 0.247).  Post hoc comparisons revealed significant differences in 
percentage freezing between the A/A group and the A/V (p < 0.01, d = 1.16) and V/A (p 
< 0.05, d = 1.03) groups.  Percentage freezing for the V/V group was also found to be 
significantly different from the A/V (p < 0.01, d = 1.21) and V/A (p < 0.05, d = 1.06)  
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Figure 5 Effects of intra-BNST ALLO infusions on the acquisition and expression 
of contextual and cued fear.   
A) Representative thionin-stained coronal section showing cannula placements. B) Schematic 
coronal sections showing infusion sites for vehicle (VEH) or allopregnanolone (ALLO). 
Experiment 1 sites are indicated by circles and Experiment 3 sites are indicated by triangles. 
Coronal brain section images are adapted from Swanson (2003). C) Mean percentage of freezing 
(± SEM) during the conditioning session (data are shown for a 3-min pre-trial period followed 
by five tone-shock pairings). Freezing was quantified before the first trial (baseline, BL) and 
during the 1-min period after each trial. D) Mean percentage of freezing (± SEM) averaged 
across the 10-min context test. The drug states for each group are indicated by a label on each 
bar indicating the drug infused before conditioning followed by the drug infused before testing 
(V for VEH, A for ALLO). The V/V group differed from the V/A (p < 0.01) and A/V (p < 0.05) 
groups. The A/A group differed from the V/A (p < 0.05) and A/V (p < 0.01) groups. E) Mean 
percentage of freezing (± SEM) averaged across each 1-min period after four tone presentations. 
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groups.  These data indicate that training and testing under the same drug state results in 
the expression of higher levels of contextual fear. 
In contrast, differences in drug state between training and testing did not affect 
freezing in response to cued fear (Figure 5E).  A factorial ANOVA with training state 
and testing state as between-subjects variables and trial number as the within-subject 
variable revealed no significant main effect of training state (F(1,19) = 1.9,  p = 0.18, η2 = 
0.089) or testing state (F(1,19) = 0.032,  p = 0.86, η2 = 0.001) and no significant 
interaction between training state and testing state (F(1,19) = 0.86,  p = 0.37, η2 = 0.039).  
These data indicate that drug state during training or testing does not influence the 
expression of cued fear. 
 
Effects of intra-BLA ALLO on the acquisition and expression of contextual and 
cued fear 
Histology 
A photomicrograph of a thionin-stained brain section shows the representative 
bilateral placement of cannulae targeted to the BLA (Figure 6A).  Figure 6B depicts 
cannula placements for all subjects used in the analysis for Experiment 2.  Of the 64 rats 
implanted, 12 were excluded due to improper cannula placement.  Additional subjects 
were excluded due to loss of head caps (n = 2) and blocked cannulae (n = 2).  This 
yielded the following group sizes: V/V (n = 14), A/A (n = 11), A/V (n = 10), and V/A (n 
= 13).  All subjects included had tip placements localized to the BLA.  Cannula 
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placements for Experiment 2 were distributed from -2.45 to -3.70 mm relative to 
bregma, with the majority between -2.85 and -3.25 mm. 
Behavior 
During conditioning, initial freezing for VEH- and ALLO-treated animals was 
negligible and then steadily rose across tone-shock presentations (Figure 6C).  A 
repeated measures ANOVA with a between-subjects variable of drug group revealed a 
significant main effect of trial (F(5,230) = 53, p < 0.0001, η2 = 0.527) but neither an effect 
of drug state prior to training (F(1,46) = 1.1, p = 0.3, η2 = 0.023) nor an interaction 
between the two (F(5, 230) = 1.6, p = 0.17, η2 = 0.016).  Therefore, regardless of drug 
manipulation prior to training, all subjects acquired conditioned fear at similar rates.   
Context testing showed that subjects receiving ALLO prior to training (A/V), 
testing (V/A), or both (A/A) had reduced freezing compared to those receiving VEH 
prior to both training and testing (V/V; Figure 6D).  A factorial ANOVA with between-
subjects variables of training state and testing state revealed a significant main effect of 
testing state (F(1,44) = 12, p < 0.01, η2 = 0.187), but not training state (F(1,44) = 0.64, p = 
0.43, η2 = 0.01).  There was, however, a significant interaction between training state 
and testing state (F(1,44) = 8.8, p < 0.01, η2 = 0.134).  Post hoc analysis revealed 
significant differences between the V/V group and all other groups (p < 0.05, d = 1.04 
for A/V; p < 0.01, d = 1.24 for A/A; p < 0.0001, d = 2.24 for V/A). 
Similar results were found with drug infusions prior to cued fear testing; animals 
treated with VEH prior to both training and testing had elevated levels of freezing 
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Figure 6 Effects of intra-BLA ALLO infusions on the acquisition and expression of 
contextual and cued fear.  
A) Representative thionin-stained coronal section showing cannula placements. B) Schematic 
coronal sections showing infusion sites for vehicle (VEH) or allopregnanolone (ALLO). 
Experiment 2 sites are indicated by circles. Coronal brain section images are adapted from 
Swanson (2003). C) Mean percentage of freezing (± SEM) during the conditioning session (data 
are shown for a 3-min pre-trial period followed by five tone-shock pairings). Freezing was 
quantified before the first trial (baseline, BL) and during the 1-min period after each trial. D) 
Mean percentage of freezing (± SEM) averaged across the 10-min context test. The drug states 
for each group are indicated by a label on each bar indicating the drug infused before 
conditioning followed by the drug infused before testing (V for VEH, A for ALLO). The V/V 
group differed from the A/A (p < 0.01), V/A (p < 0.0001), and A/V (p < 0.05) groups. E) Mean 
percentage of freezing (± SEM) averaged across each 1-min period after four tone presentations. 
The V/V group differed from the A/A (p < 0.01), V/A (p < 0.0001), and A/V (p < 0.01) groups. 
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compared to other groups (Figure 6E).  A factorial ANOVA revealed a significant main 
effect of testing state (F(1,44) = 7.4, p < 0.01, η2 = 0.117), but not training state (F(1,44) = 
2.7, p = 0.11, η2 = 0.042).  A significant interaction between training state and testing 
state was also found (F(1,44) = 9.0, p < 0.01, η2 = 0.143).  Post hoc analysis revealed 
significant differences between the V/V group and all other groups (p < 0.01, d = 1.19 
for A/A; p < 0.01, d = 1.26 for A/V; p < 0.0001, d = 1.56 for V/A). 
 
Contribution of intra-BNST ALLO to interoceptive and exteroceptive states 
Histology 
Cannula placements for all subjects in Experiment 3 are depicted in Figure 5B.  
Of the 64 rats implanted, eight were excluded due to improper cannula placement.  This 
yielded the following group sizes: None (n = 12), Context (n = 16), Drug (n = 12), and 
Context & drug (n = 16).  All subjects included had tip placements localized to the 
anterior BNST.  Cannula placements for Experiment 3 were distributed from 0.00 to -
0.46 mm from bregma, with the majority between -0.11 and -0.26 mm.  
Behavior 
In order to explore the possible contribution of intra-BNST ALLO to 
interoceptive and exteroceptive aspects of conditioned context, the design illustrated in 
Figure 7A was devised for Experiment 3.  All animals were initially infused with ALLO 
and then conditioned in Context A.  The following day, subjects were tested under one 
of four assigned context shift test conditions: 1) the same drug state and context (None), 
2) the same drug state but different context (Context), 3) the same context but different 
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drug state (Drug), or 4) different context and drug state (Context & drug).  Acquisition 
of fear conditioning did not differ between subjects assigned to these groups (data not 
shown).  Baseline freezing was low across all groups and as seen in ALLO-treated 
animals from Experiment 1, rats exhibited robust freezing after the onset of tone-shock 
trials.  A repeated measures ANOVA with a between-subjects variable of assigned 
context shift test condition (None, Context, Drug, or Context & drug) and a within-
subject variable of trial number revealed a significant main effect of trial number (F(5,260) 
= 53, p < 0.0001, η2 = 0.493) but no significant main effect (F(3,52) = 1.4, p = 0.26, η2 = 
0.074) or interaction of context test assignment (F(15,260) = 0.99, p > 0.05, η2 = 0.027).  
Therefore, subjects in all assigned test groups acquired conditioned fear similarly across 
the five trials. 
During context testing, changes in both context and drug state as well as a change 
in drug state alone had suppressive effects on freezing behavior (Figure 7B).  There was 
a significant main effect of both test context (F(1,52) = 4.1, p < 0.05, η2 = 0.065) and test 
drug state (F(1,52) = 6.5, p < 0.05, η2 = 0.103), but no interaction between the two factors 
(F(1, 52) = 0.47, p = 0.50, η2 = 0.007).  Post hoc analysis revealed a significant difference 
between None and Drug groups (p < 0.05, d = 0.99) and None and Context & drug 
groups (p < 0.01, d = 1.46).  In addition, a trend towards a significant difference between 
percentage freezing expressed by None and Context groups (p = 0.06, d = 0.78) was 
obtained.  These data indicate that a change in the interoceptive drug state of the BNST 
at test can impair recall of a fear-conditioned exteroceptive context. 
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Figure 7 Contribution of intra-BNST ALLO to interoceptive and exteroceptive 
states.  
A) Schematic diagram showing the design for Experiment 3. For conditioning, all animals were 
in the same interoceptive (infused with allopregnanolone; ALLO) and exteroceptive (Context A) 
states. For context testing, animals were assigned to one of four groups with varying degrees of 
shift in interoceptive and exteroceptive states: 1) the None group had no shifts, 2) the Context 
group had a shift in exteroceptive state (infused with ALLO, exposed to Context B), 3) the Drug 
group had a shift in interoceptive state (infused with vehicle, exposed to Context A), and 4) the 
Context & drug group had shifts in both states (infused with vehicle, exposed to Context B). B) 
Mean percentage of freezing (± SEM) averaged across the 10-min context test. The None group 
differed from the Drug (p < 0.05) and Context & drug groups (p < 0.01). 
 
 
Discussion 
The present study demonstrates that intra-BNST administration of ALLO results 
in state-dependent contextual fear in male rats.  Thus, our previous finding that intra-
BNST ALLO suppresses contextual fear (Nagaya et al., 2015) may not be due to a 
simple pharmacological impairment of context-specific fear expression.  Rather, our 
current data suggest that intra-BNST ALLO may induce an interoceptive state that 
becomes conditioned to exteroceptive aversive stimuli.  This effect of ALLO was unique 
to the BNST, insofar as ALLO infusions into the BLA produced a state-independent 
impairment in both the acquisition and expression of conditional freezing to context and 
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cue.  The state-dependent modulation of contextual fear by intra-BNST ALLO suggests 
a novel mechanism by which gonadal steroids and their metabolites might influence the 
acquisition and expression of fear memories. 
In addition to producing state-dependent contextual fear, we found, 
unexpectedly, that ALLO infused into the BNST prior to conditioning facilitated the 
acquisition of post-shock freezing.  The increase in post-shock freezing after ALLO 
infusion was unique to the BNST and, did not necessarily result in increased contextual 
fear—in fact, the opposite was true when VEH rather than ALLO was administered prior 
to testing.  Infusion of ALLO or other GABAR modulators into the BNST prior to fear 
conditioning have not been reported, although chemical lesions of the BNST have been 
found to either impair fear to context-like, long-duration stimuli (Waddell et al., 2006) or 
have no effect on contextual fear (LeDoux et al., 1988).  The increased level of freezing 
we observed in ALLO-treated animals during acquisition could arise from enhanced 
synaptic inhibition within the BNST resulting in 1) increased activity in anxiogenic 
circuits and/or, 2) facilitated acquisition of a US association with the drug-induced 
interoceptive state.  ALLO infusion into the BNST may shift GABAergic inhibition such 
that anxiogenesis is promoted during fear conditioning.  Optogenetic and in vitro slice 
recording studies support the presence of heterogeneous subnuclei within the BNST that 
have opposing functions in regulating anxiety (Gungor et al., 2015; Jennings et al., 2013; 
Kim et al., 2013).  GABAergic inputs from the lateral portion of the central amygdala 
(CeL) have been proposed to inhibit neurons in the anterolateral portion of the BNST 
(BNST-AL), which in turn, inhibit neurons in the anteromedial portion of the BNST 
  76 
(BNST-AM) and modulate fear (Gungor and Pare, 2014; Haufler et al., 2013).  Infused 
ALLO may facilitate CeL inhibition and thereby increase disinhibition of BNST-AM 
neurons that generate fear.  Alternatively, fear acquisition in ALLO-treated animals may 
be enhanced by the 10 min pre-conditioning exposure to ALLO, which could promote 
greater salience between the US (footshock) and interoceptive state rather than the tone 
CS or context.  In other words, ALLO within the BNST may serve as a ‘cue’ that 
becomes associated with footshock (Fanselow, 1980), thereby facilitating acquisition in 
ALLO-treated but not VEH-treated animals.  Indeed, the greater level of freezing 
induced by ALLO infusion is apparent after the first conditioning trial (Figure 5C).  
Of course, it is of considerable interest that despite increasing post-shock 
freezing, ALLO in the BNST produced marked deficits in contextual freezing during 
retention testing when infused either before conditioning or before testing.  While this 
might suggest a general inhibitory effect of GABAR modulation on the acquisition and 
expression of fear, animals for which ALLO was infused prior to both fear conditioning 
and retention testing exhibited high levels of conditioned freezing.  This suggests that 
impairments in contextual freezing in animals experiencing differing drug states were 
due to state-dependent generalization deficits.  In particular, we suggest that a shift in the 
interoceptive context between conditioning ‘on drug’ and testing ‘off drug’ (and vice 
versa) reduced contextual fear.  To our knowledge, this is the first time state-dependent 
drug effects have been reported for the BNST.  Not surprisingly, given that the BNST 
has been predominantly implicated in contextual fear, state dependence was not 
observed for cued fear (Hammack et al., 2004; Resstel et al., 2008; Sullivan et al., 2004; 
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Zimmerman and Maren, 2011).  State-dependent learning occurs when the learned event 
is more strongly recalled when training and testing occur in the same “state” (Overton, 
1991).  The state may refer to endogenous cues that create an interoceptive context 
resulting from drug consumption or alteration of brain excitation through receptor 
modulation as opposed to external contextual attributes such as lighting or odor. 
The present finding that the BNST is involved in a state-dependent form of 
contextual fear is somewhat surprising and casts previous work on its role in fear 
learning and expression in a different light.  For example, in Experiment 3, matching of 
the interoceptive and exteroceptive contexts resulted in the greatest degree of expressed 
fear, whereas testing under different interoceptive and exteroceptive contexts resulted in 
the lowest degree of expressed fear.  Not surprisingly, animals trained and tested with 
either the same interoceptive or the same exteroceptive context showed intermediate 
levels of fear.  Differences in freezing of animals tested in the same drug state but 
different contexts approached significance (p = 0.06; Figure 7B).  These results suggest 
that the interoceptive (e.g., hormonal) contextual representation generated by the BNST 
may carry as much weight as the exteroceptive representation of spatial context 
generated by the hippocampus.  In other words, the level of activation within the BNST 
may serve as a critical component to the overall “context” encoded during fear 
acquisition. 
The ability of ALLO to induce state dependence in contextual fear learning is 
perhaps not surprising when the precedence of GABAR modulators in state-dependent 
learning is considered.  Studies involving active avoidance in the T-maze have shown 
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that barbiturates, such as pentobarbital, and steroids, such as hydroxydione and 
progesterone, can induce state-dependent learning upon systemic administration 
(Overton, 1964; Stewart et al., 1967).  Passive avoidance has also been shown to be 
state-dependent in ovariectomized females treated with progesterone (Ebner et al., 
1981), which can be metabolized to ALLO, and in intact males treated with diazepam or 
muscimol (Nakagawa et al., 1993).  More recently, Jovasevic et al. (2015) have 
demonstrated that state-dependent contextual fear learning can be induced by altering 
interoceptive state with gaboxadol infusion into the hippocampus prior to conditioning, 
suggesting that activation of extrasynaptic GABARs can “gate” access to contextual fear 
memory (Holmes and Chen, 2015). 
Although the effects we observed of intra-BLA ALLO infusion on acquisition 
and expression of contextual and cued fear are distinctly different from those observed 
for the BNST, they are in concordance with previous studies involving pharmacological 
blockade of synaptic activity within the BLA (Fanselow and Kim, 1994; Harris and 
Westbrook, 1998; Helmstetter and Bellgowan, 1994; Maren and Holt, 2004; Maren et 
al., 1996b; Muller et al., 1997).  They are also consistent with ALLO acting to increase 
GABAergic tone and inhibit activity within the BLA.  Helmstetter and Bellgowan 
(1994) found that infusions of muscimol (prior to conditioning or testing) produce 
deficits in the expression of conditioned contextual fear (cued fear was not examined), 
suggesting that essential neural activity within the BLA is required for both acquisition 
and expression of conditioned contextual fear.  Similarly, Maren and Holt (2004) 
reported deficits in both conditioned contextual and cued fear with pre-conditioning and 
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pre-testing infusion of muscimol into the BLA.  Such effects of pharmacological 
suppression of synaptic transmission are not limited to GABAR agonists but have also 
been observed with GABAR potentiators such as midazolam, a benzodiazepine (Harris 
and Westbrook, 1998).  The effects of ALLO infusion into the BLA are also very similar 
to the effects of APV infusion into the BLA, except that ALLO did not attenuate 
freezing during acquisition of contextual fear whereas APV significantly decreased 
freezing during conditioning (Maren et al., 1996b) and during testing (Fanselow and 
Kim, 1994; Maren et al., 1996b).  The effects of APV were not due to state-dependent 
decrements in generalization, were evident when infusions were given before 
conditioning, testing, or both, and did not affect consolidation.  Thus, the Maren et al. 
(1996b) study supports the role of NMDA receptors in the acquisition and expression of 
conditioned contextual fear.  Interestingly, the effects we observed of ALLO infusions 
prior to conditioning and testing on contextual and cued fear look very similar to those 
seen by Muller et al. (1997).  They found that muscimol infusions into the lateral and 
basal amygdala suppress both context- and cue-dependent freezing when administered 
before conditioning, testing, or both.  When considered along with previous reports, our 
present findings on the suppressive effects of intra-BLA ALLO on contextual and cued 
fear suggest that ALLO, like muscimol and APV, is blocking synaptic transmission 
essential to acquisition and expression of conditioned fear.  Given that ALLO was not 
administered post-training, we cannot directly address whether or not consolidation was 
affected. 
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We acknowledge that the effects of ALLO we observed could involve molecular 
mechanisms other than GABAR potentiation.  ALLO may modulate other ionotropic 
neurotransmitter receptors (5-HT3 and NMDA; Frye et al., 2014) or act at nonclassical 
steroid receptors (membrane progesterone and pregnane xenobiotic; Porcu et al., 2016).  
In addition, local availability of metabolic enzymes could convert ALLO into its 
precursor, dihydroprogesterone, which acts at intracellular progesterone receptors 
(Rupprecht et al., 1993), or its 3β epimer, isoallopregnanolone, which can antagonize 
ALLO-mediated potentiation of GABARs (Johansson et al., 2016). 
 
Conclusions 
We have presented evidence that local infusion of ALLO into the BNST 
generates state-dependent contextual fear in male rats.  This finding strongly suggests 
that the effects of intra-BNST ALLO we recently observed (Nagaya et al., 2015) are due 
to impaired retrieval of conditioned contextual fear due to ALLO’s role as an 
interoceptive component of the conditioned context.  It also suggests that previously 
reported deficits in contextual freezing following pre-test administration of ALLO and 
other GABAergic modulators are due to the pharmacologically induced state-dependent 
nature of contextual fear learning.  Additionally, pre-training administration of 
GABAergic modulators may similarly produce deficits in performance if they are absent 
during testing.  The implications of our work with regards to anxiety-related disorders 
are that levels of endogenous gonadal steroids and their metabolites may shape CS-US 
associations during acquisition and serve as an important component to retrieval of 
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conditioned context-specific fear.  Consideration of hormonally induced interoceptive 
state may contribute to more effective treatment of disorders such as PTSD. 
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CHAPTER IV 
DIFFERENTIAL EFFECTS OF PROGESTERONE ON CONDITIONED FEAR 
IN CYCLING AND OVARIECTOMIZED FEMALE RATS 
 
Overview 
 Women are more susceptible to stress and trauma-related disorders, suggesting a 
role for ovarian hormones in modulating fear and anxiety.  In both human and rodent 
studies, estrogen and progesterone have been shown to influence fear learning during 
acquisition, expression, and extinction.  Recently, we have shown that allopregnanolone 
(ALLO), a progesterone (PROG) metabolite and GABAA receptor potentiator, can 
modulate conditioned contextual fear through its actions in the bed nucleus of the stria 
terminalis (BNST).  In male rats, local administration of ALLO into the BNST appears 
to confer state-dependence to fear learning such that subjects conditioned and tested 
under ALLO have higher levels of fear than those conditioned or tested without ALLO.  
In females, ALLO levels follow the fluctuations in PROG during the estrous cycle.  In 
order to determine whether natural fluctuations of PROG are associated with state-
dependent contextual fear in females, animals received Pavlovian fear conditioning 
during one of two estrous cycle phases: either late diestrus (DI; low PROG) or late 
proestrus (PRO; high PROG).  Following conditioning, animals were tested for 
contextual fear in either the same or different hormonal state.  C-fos immunoreactivity 
was used to assess neuronal activation within the BNST following testing under low and 
high PROG cycle phases.  We found that subjects conditioned and tested in PRO had 
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elevated levels of contextual fear compared to subjects conditioned in DI and tested in 
PRO, suggesting asymmetric state-dependent effects of PROG on fear learning.  This 
effect did not carry over to an ovariectomized model with PROG replacement.  
Together, these results provide evidence for state-dependent effects of PROG on 
contextual fear in naturally cycling female rats.   
 
Introduction 
 It is well-established that context affects aversive memories in both rodent and 
human studies (Maren et al., 2013).  During all aspects of Pavlovian fear conditioning 
including acquisition, extinction, recall, and reinstatement, context encoding and context 
shifts affect memory (Bouton, 2002; Bouton and Bolles, 1979; Bouton and King, 1983; 
Matus-Amat et al., 2004; Westbrook et al., 2002).  Typically, contextual stimuli are 
thought to involve external cues such as lighting, scent, or environmental constraints, 
however, interoceptive contextual cues including satiety, stress, and drug-induced or 
hormonal state may be just as important.   
In particular, gonadal steroid hormones and their metabolites are known to affect 
aversive memories (Chang et al., 2009; Gupta et al., 2001; Milad et al., 2009; Nagaya et 
al., 2015; Toufexis et al., 2004) and may serve as internal contextual cues.  Gonadal 
steroids have been shown to enhance or dampen fear memories during acquisition, 
extinction, and testing, however, the concordance between hormonal states during 
conditioning and testing has received less attention.  Specifically, differences in 
hormonal state between conditioning and training can lead to apparent learning deficits 
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due to state-dependent learning, a phenomenon in which memories are better recalled 
when retrieved in the same state in which they were acquired (Overton, 1964; 1991).   
State-dependent learning has been reported in both humans and animal models 
(Gill et al., 2015; Goodwin et al., 1969; Overton, 1966; Rezayof et al., 2008; Rosa et al., 
2014).  While most studies of state-dependent learning have focused on systemic effects, 
recent work suggests both the hippocampus (Jovasevic et al., 2015) and the bed nucleus 
of the stria terminalis (BNST; Acca et al., 2017) are particular sites that mediate these 
effects, whereas the BLA does not (Acca et al., 2017; Helmstetter and Bellgowan, 1994). 
Furthermore, the hippocampus encodes interoceptive cues through ethanol drinking in 
mice during fear conditioning (Yoo et al., 2017).  Both the hippocampus (Holland and 
Bouton, 1999; Maren et al., 1997; Matus-Amat et al., 2004; Phillips and Ledoux, 1992) 
and the BNST (Hammack et al., 2004; Nagaya et al., 2015; Sullivan et al., 2004; 
Zimmerman and Maren, 2011) are important loci for contextual processing in fear 
conditioning and therefore may also be critical regions for interoceptive contextual 
processing as well.   
Recently, we showed that allopregnanolone (ALLO) in the BNST of male rats 
results in state-dependent contextual fear (Acca et al., 2017).  ALLO is a metabolite of 
progesterone (PROG) and a potent potentiator of GABAA receptors.  ALLO levels 
fluctuate along with PROG levels across the estrous cycle in female rodents (Corpéchot 
et al., 1993) suggesting that PROG may also contribute to state-dependent memory.  To 
our knowledge, no previous study has directly examined possible state-dependent effects 
of PROG on fear conditioning in naturally cycling rats or in ovariectomized (OVX) rats 
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given exogenous PROG.  Here, we sought to determine if high and low PROG levels 
within the estrous cycle in female rats contribute to state-dependent contextual fear and 
differential neuronal activation within the BNST.  Furthermore, we explored if this same 
learning mechanism applied to OVX subjects with exogenous PROG replacement.  
 
Materials and Methods 
Subjects 
Female Long-Evans rats (200-224 g upon arrival; Blue Spruce) were purchased 
from a commercial supplier (Envigo, Indianapolis, IN, USA).  Rats were individually 
housed in clear plastic cages on a 14:10 h light:dark cycle (lights off at 5:00 P.M.) in a 
temperature and humidity controlled room with unrestricted access to food and water.  
For 5 consecutive days, rats were handled for roughly 20 s to habituate them to the 
female experimenters.  All behavioral procedures took place in the late afternoon during 
the light cycle.  Experiments were carried out in accordance with guidelines approved by 
the Institutional Animal Care and Use committees at Texas A&M University.   
 
Behavioral Apparatus  
All behavioral procedures occurred in 8 identical observation chambers (30 x 24 
x 21 cm; Med Associates, St. Albans, VT, USA) composed of Plexiglas rear wall, 
ceiling, and front-hinged door and 2 aluminum sides.  One sidewall contained a speaker 
for delivery of the auditory stimulus and the opposite sidewall held an incandescent 
light.  The floor was composed of 19 stainless steel rods (4 mm in diameter) spaced 1.5 
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cm apart (center to center).  Rods were connected to a shock source and solid-state grid 
scrambler (Med Associates) for shock delivery.  Underneath the rods was a removable 
stainless steel tray for odor manipulations.  Spy cameras were mounted above each 
chamber for live monitoring of rodent behavior.  All observation chambers were housed 
in sound-attenuating cabinets with fans to provide background noise (65 dB).  
Locomotor activity was measured via Threshold Activity Software (Med 
Associates).  Each chamber was situated on a load cell that was previously calibrated to 
a specific displacement to convert movement into an electrical signal.  Signals were 
digitized at 5 Hz yielding one observation every 200 ms. Freezing, or immobility aside 
from that which is necessary for respiration, was only scored if the rat was immobile for 
at least 1 s.   
 Behavioral procedures were conducted in one of two contexts.  Context “A”, 
used for conditioning and context testing, consisted of each chamber being wiped down 
with 1% acetic acid with a small amount left in the removable tray beneath the rods.  
White fluorescent room lights, chamber lights, and fans were all on, and cabinet doors 
were left open.  Rats were transported to and from the vivarium in white plastic boxes.  
Context “B”, used for tone testing, was cleaned in a similar fashion but with 1% 
ammonium hydroxide.  Red fluorescent lighting was used in the room, but chamber 
lights remained off and cabinet doors were closed.  Fans remained on to mask 
background noise.  Black plastic boxes were used to transport rats to and from the 
vivarium for behavioral testing.   
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Experiment 1: Effects of Estrous Cycle Phase on the Acquisition and Expression of 
Contextual Fear  
Estrous cycle tracking 
After 5 days of acclimation to the housing conditions, vaginal smears were 
obtained daily at 11 A.M. for at least 10 consecutive days to ensure normal cycling.  
Cotton swabs moistened with distilled water were used and cells were visualized under a 
light microscope at 100× and characterized according to (Goldman et al., 2007).  Cycle 
tracking continued throughout behavioral testing and rats with irregular cycles were 
excluded from the analysis.   
Behavioral procedure 
In order to examine state-dependent effects of estrous cycle phase on contextual 
fear, a 2 × 2 × 2 factorial design was used.  Late proestrus (PRO) was selected for high 
circulating PROG levels and late diestrus (DI) was selected for low circulating PROG 
levels.  Subjects in the Shock group were conditioned in either PRO or DI and then 
allowed to cycle until they reached that same phase or a different phase for contextual 
fear testing, thus yielding the following groups: P/P, D/D, P/D, and D/P (P = PRO, D = 
DI; the first letter indicates the estrous cycle phase on conditioning day and the second 
letter indicates the estrous cycle phase on testing day).  For conditioning, rats were 
transported to the behavior room in white plastic boxes (Context A).  Conditioning 
consisted of a 3-min baseline period, followed by 5 tone (CS; 10 s, 80 dB, 2kHz)-shock 
(US; 2 s, 1 mA) pairings in which the shock immediately followed the tone.  A 1-min 
inter-trial interval (ITI) was interspersed between each CS-US pairing, including a 1-min 
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period following the last shock.  Immediately after conditioning, rats were transported 
back to their home cages in white plastic boxes.  Estrous cycle continued to be tracked 
until rats were in either the same or different cycle phase (3-6 days) for context testing.  
Context testing occurred in Context A and rats were transported to the conditioning 
chambers again in white plastic boxes.  Freezing behavior was assessed over a 10-min 
period in the absence of any tones or shocks.  Immediately following context testing rats 
were returned to their home cages.  A No Shock group was included as a control for c-
Fos immunoreactivity.  No Shock subjects received the same treatment as the Shock 
subjects except that during conditioning they did not receive shocks.  All other 
experimental procedures were identical.  Due to the complexity of matching estrous 
cycles in this design and our focus on contextual fear processing, tone testing was not 
performed.   
Immunohistochemistry  
Ninety minutes after context testing, rats were overdosed with sodium 
pentobarbital (100 mg/kg), subjected to cardiac puncture for blood sampling (see below), 
and transcardially perfused with 0.9% saline and 10% formalin.  Brains were rapidly 
dissected and stored for 18 h in 10% formalin at 4 °C before being transferred to 30% 
sucrose-formalin.  Coronal brain sections (40 µm) were made on a cryostat maintained at 
-20 °C and stored in phosphate-buffered saline (pH 7.4) with 0.01% sodium azide 
(VWR, Radnor, PA, USA) until processing. 
Immunohistochemistry was performed on free-floating brain sections.  Sections 
were first washed in Tris-buffered saline (TBS; pH 7.4) followed by 0.3% hydrogen 
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peroxide (H2O2; Sigma-Aldrich, St. Louis, MO, USA) in TBS.  After three washes, 
samples were incubated overnight with rabbit anti-c-Fos polyclonal antibody (ABE457; 
EMD Millipore, Billerica, MA, USA) diluted 1:10,000 in 0.1 % Tween-20 in TBS 
(TBST).  The next day following serial washes, sections were incubated for 1 h in 
biotinylated donkey anti-rabbit secondary antibody (1:1,000 in TBST, Jackson 
ImmunoResearch Laboratories, West Grove, PA, USA).  Upon completion, sections 
were washed and further incubated for 45 min in avidin-biotin complex (ABC; 1:1,000 
in TBST; VECTASTAIN ABC Elite HRP kit, Vector Laboratories, Burlingame, CA, 
USA).  Slices were then stained for 10 min with a combination of 0.025% 3,3'-
diaminobenzidine tetrahydrochloride hydrate (Sigma-Aldrich), 0.5% nickel ammonium 
sulfate (Sigma-Aldrich) and 0.015% H2O2.  After washes, sections were mounted onto 
gelatin-subbed slides. 
Image analysis 
Two images for the anterior BNST approximately -0.11 and -0.26 posterior to 
bregma (Figure 8), according to Swanson Brain Maps (2003), were captured for 
quantification using a Zeiss Axio Imager 2 microscope.  All images were taken at 10x 
magnification.  Using representative sections from the brain map, nuclei of interest were 
outlined and standardized sections were isolated from two images.  Using ImageJ (NIH) 
automated counting feature, c-Fos positive cell counts for the oval, fusiform, medial, and 
lateral nuclei were recorded in isolated sections, averaged, and normalized to area.    
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Hormone assay 
Prior to transcardial perfusion, blood samples (approximately 2 ml) were 
collected via cardiac puncture and allowed to sit at room temperature for 45 min.   
 
 
 
Figure 8 Representative c-Fos images in the BNST.   
A) Approximately -0.11posterior to bregma.  B) Approximately -0.26 posterior to bregma.  
Lateral Ventricle (LV); Anterior Commissure (AC); BNST-OV (OV); BNST-AM (AM); BNST-
AL (AL); BNST-FU (FU).    
 
 
 
Samples then were centrifuged at room temperature for 15 min at 3,000 RPM and 
plasma was collected and stored at -80 °C until processing.  Progesterone levels were 
assayed using a progesterone ELISA kit (sensitivity 8.57 pg/ml, Enzo Life Sciences, 
Farmingdale, NY, USA) and read on a Multimode Plate Reader (PerkinElmer, Shelton, 
CT, USA).  All samples were run in duplicate at a 1:200 dilution.    
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Data analysis   
For conditioning, percentage freezing behavior was averaged across the 3-min 
baseline period, the 1-min ITI, and the 1-min post-trial period.  Freezing was averaged 
across the entire 10-min context test.  Behavioral and immunohistochemical data were 
analyzed using repeated measures or factorial analysis of variance (ANOVA) and 
presented as means ± SEMs (α = 0.05).  For post hoc examination, Fisher’s protected 
least significant difference (PLSD) was chosen.  Hormone data were analyzed by an 
independent t-test and presented as means ± SDs (α = 0.05).        
 
Experiment 2: Effects of Exogenous PROG on the Acquisition and Expression of 
Contextual and Cued Fear in OVX Rats 
Surgical procedures 
Briefly, rats were anesthetized with isoflurane (5% induction, 2% maintenance).  
They were bilaterally ovariectomized using standard aseptic surgical techniques.  A 
single dorsal skin incision was made and bilateral muscle incisions exposed the ovaries.  
On each side, the uterine horn was ligated just below the ovary and the ovary removed.  
The muscle incisions were closed with absorbable suture and skin incisions were closed 
with surgical staples.  Rats were monitored daily during a one-week recovery period 
prior to the start of behavior.   
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Drugs 
For subcutaneous injections, progesterone (PROG; 4 mg/ml, Sigma-Aldrich) was 
prepared fresh in sesame oil (VEH, Sigma-Aldrich) on Day 1 on constant heat with 
continuous stirring and then stored at room temperature and used for Days 2 and 3.  
Behavioral procedures 
In order to examine state-dependent effects of exogenous PROG on conditioned 
fear in OVX females, a 2 × 2 factorial design was used. No Shock controls were 
excluded from this experiment, as we were only interested in the behavioral effects of 
OVX females with PROG replacement.  In Experiment 1, we particularly chose late 
proestrus in order to capture the point in the estrous cycle where PROG levels were the 
highest, and subsequently ALLO levels.  Therefore, in Experiment 2 we focused solely 
on PROG replacement to isolate the possible effects to PROG and not a combination of 
estrogen and PROG.  OVX females received one of four different combinations of drug 
injections prior to conditioning and testing as follows:  Pr/Pr, V/V, Pr/V, and V/Pr (Pr = 
PROG, V = VEH; the first letter indicates the drug given on conditioning day and the 
second letter indicates the drug given on testing days).  PROG (4 mg/kg) or VEH (1 
ml/kg) was subcutaneously injected into the scruff of the neck 1 h prior to behavioral 
testing.  PROG doses were chosen from previous studies that reported physiological 
levels of circulating PROG as seen during the proestrus phase of the estrous cycle 
(Llaneza and Frye, 2009).  Conditioning occurred on Day 1 in Context A following 
procedures identical to those used in Experiment 1.  Twenty-four hours later, rats were 
injected with either the same or different drug as Day 1 and tested for contextual fear.  
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On Day 3, rats were injected with the same drug they received prior to context testing 
and were transported for tone testing in black plastic boxes.  For tone testing, animals 
were placed in Context B and monitored for a 3-min baseline period followed by 4 CS 
presentations with a 1-min ITI and a 1-min post period after the last CS.    
Hormone assay 
Immediately after tone testing on Day 3, rats were overdosed with sodium 
pentobarbital and blood samples were collected via cardiac puncture.  Progesterone 
levels were assessed as described for Experiment 1.  
Data analysis   
Data were analyzed in an identical manner to Experiment 1.  For tone testing, 
percentage freezing behavior during the 1-min ITI period between each tone presentation 
and after the final fourth tone presentation were averaged.   
 
Results 
 Experiment 1: Effects of Estrous Cycle Phase on the Acquisition and Expression of 
Contextual Fear  
Behavior 
 No Shock control animals had less than 10% freezing levels during conditioning 
(data not shown). PRO and DI subjects did not differ in acquisition of fear.  All subjects 
had little to no freezing behavior prior to the first shock with increased freezing over the 
5 trials (Figure 9).  A repeated measures ANOVA with a between-subjects factor of 
training state (PRO or DI) showed a significant main effect of trial number (F(5, 250) = 
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32.01, p < 0.0001) on freezing.  There was no significant difference between estrous 
cycle phases (F(1, 50) = 0.08, p = 0.77) or an interaction between estrous cycle phase and 
trial number (F(5, 250) = 0.16, p = 0.98).  Thus, each group acquired similar levels of fear 
as indexed by freezing behavior.   
 No Shock controls maintained freezing levels below 10% throughout context 
testing (data not shown).  Subjects in PRO only during testing (D/P) showed reduced 
levels of freezing compared to those conditioned and tested in PRO (P/P), those 
conditioned and tested in DI (D/D), and those in DI only during testing (P/D) (Figure 9).  
A factorial ANOVA revealed a significant main effect of cycle phase at conditioning 
(F(1, 48) = 4.293, p = 0.04), but not cycle phase at testing (F(1, 48) = 1.33, p = 0.26).  There 
was also a significant interaction between cycle phase at conditioning and at testing (F(1, 
48) = 6.03, p = 0.02).  Post hoc analysis showed significant differences between P/P and 
D/P (p < 0.01), P/D and D/P (p < 0.05), and D/D and D/P (p < 0.05).  Together, these 
data suggest only subjects trained in DI and tested during PRO had reduced levels of 
contextual fear.   
Fos analysis 
We next examined Fos expression in the anterolateral (BNST-AL), anteromedial 
(BNST-AM), oval (BNST-OV), and fusiform (BNST-FU) nuclei of the BNST (Figure 
10) due to previous results suggesting its role in state-dependent context fear memories 
following ALLO administration in male rats (Acca et al., 2017).  Surprisingly, there was 
no significant main effect of footshock group (No Shock vs. Shock) in any region 
(BNST-AL, F(1,89) = 0.37, p > 0.05; BNST-AM, F(1,89) = 0.34, p > 0.05; BNST-OV, 
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Figure 9 Effects of estrous cycle phase on the acquisition and expression of 
contextual fear.   
A) Mean percentage of freezing (± SEM) during the conditioning session (data are shown for a 
3-min pre-trial period followed by five tone-shock pairings) for animals in proestrus (PRO, open 
circles) or diestrus (DI, filled circles). Freezing was quantified before the first trial (baseline, BL) 
and during the 1-min period after each trial. B) Mean percentage of freezing (± SEM) averaged 
across the 10-min context test. Estrous cycle phases are indicated by D for DI and P for PRO 
with conditioning phase followed by testing phase.  The D/P group differed from the D/D group 
(p = 0.01), the P/P group (p = 0.001), and the P/D group (p = 0.02).  Group sizes consisted of 11 
in D/D, 13 in P/P, 17 in D/P, and 11 in P/D. 
 
 
 
F(1,89) = 0.84, p > 0.05; BNST-FU, F(1,89) = 0.38, p > 0.05).  BNST-AL showed a 
significant main effect of cycle phase at conditioning (F(1,89) =  5.49, p = 0.02) and post 
hoc analysis revealed a significant difference between those conditioned in PRO and 
those conditioned in DI (p < 0.05).  There was also a significant interaction between 
footshock group and cycle phase at testing (F(1,89) = 6.30, p = 0.01).  A significant main 
effect of cycle phase at testing in BNST-FU (F(1,89) = 5.61, p = 0.02) was found, but no 
effect of cycle phase at conditioning (F(1,89) = 0.06, p > 0.05).  There were also no 
significant main effects or interactions for both BNST-OV and BNST-AM.   
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Figure 10 Effects of estrous cycle phase on c-Fos expression in the BNST following 
context testing.   
Estrous cycle phases are indicated by D for diestrus (DI) and P for proestrus (PRO) with 
conditioning phase followed by testing phase.  A) Mean (±SEM) cell counts/mm2 for Fos-
positive neurons in the oval nucleus of the BNST (BNST-OV).  B) Mean (±SEM) cell 
counts/mm2 for Fos-positive neurons in the anterolateral nucleus of the BNST (BNST-AL).  No 
Shock D/P and Shock D/D groups differed from the Shock P/P group (p < 0.01).  C) Mean 
(±SEM) cell counts/mm2 for Fos-positive neurons in the anteromedial nucleus of the BNST 
(BNST-AM).  No Shock D/P and Shock D/D groups differed from the Shock D/P group (p < 
0.05).  D) Mean (±SEM) cell counts/mm2 for Fos-positive neurons in the fusiform nucleus of the 
BNST (BNST-FU).   
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Hormone assay 
On testing day, plasma progesterone levels were significantly higher in animals 
in PRO compared to animals in DI (t(95) = 21.23, p < 0.0001), thus supporting the cycle 
phase assignments based on estrous cycle tracking (Table 1).  
 
 
 
Experiment Group 
Mean PROG 
Levels 
(ng/mL) 
Standard  
Deviation  
1 
cycling rats 
DI 10.57 5.8 
PRO 48.18 10.76 
2 
OVX rats 
VEH 10.07 3.44 
PROG 44.55 9.4 
 
Table 2 Mean plasma PROG levels following context testing in Experiment 1 and 
tone testing in Experiment 2.  
In Experiment 1, mean plasma PROG levels were significantly different between DI and PRO 
groups (p < 0.001).  In Experiment 2, mean plasma PROG levels were significantly different 
between VEH and PROG groups (p < 0.001).   
 
 
 
Experiment 2: Effects of Exogenous PROG on the Acquisition and Expression of 
Contextual and Cued Fear in OVX Rats 
Behavior 
 Acquisition of fear did not differ between PROG and VEH subjects (Figure 
11A).  Levels of freezing remained low prior to the first shock and increased similarly 
across all 5 trials.  A repeated measures ANOVA revealed no significant difference 
between drug treatment groups during conditioning (F(1, 46) = 0.04, p = 0.85).  There was, 
however, a significant main effect of trial number (F(5, 230) = 31.64, p < 0.0001).  No 
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interaction between the two was found (F(5, 230) = 0.37, p = 0.87).  Thus all subjects, 
regardless of drug treatment acquired fear in a similar fashion.  
 Context testing revealed no significant main effects of drug group for 
conditioning or testing, nor an interaction between the two (Figure 11B; drug at 
conditioning, F(1,44) = 3.67, p = 0.06; drug at testing, F(1, 44) = 0.11, p = 0.74; interaction, 
F(1, 44) = 1.45, p = 0.23).  Post hoc analysis did reveal a significant difference between 
subjects conditioned and tested on VEH (V/V) and those conditioned on PROG and 
tested on VEH (Pr/V; p < 0.05).  Tone testing (Figure 11C) revealed no significant main 
effect of drug group at conditioning (F(1,44) = 0.71, p = 0.40) or drug group at testing  
(F(1,44) = 0.93, p = 0.34).   
 
 
 
Figure 11 Effects of exogenous PROG on the acquisition and expression of 
contextual and cued fear in OVX female rats.  
A) Mean percentage of freezing (± SEM) during the conditioning session (data are shown for a 
3-min pre-trial period followed by five tone-shock pairings) for animals treated with vehicle 
(VEH, filled circles) or progesterone (PROG, open circles). Freezing was quantified before the 
first trial (baseline, BL) and during the 1-min period after each trial. B) Mean percentage of 
freezing (± SEM) averaged across the 10-min context test. Drug treatment groups are indicated 
by V for VEH and Pr for PROG with conditioning treatment followed by testing treatment. The 
V/V group differed from the Pr/V (p = 0.03) group. C) Mean percentage of freezing (± SEM) 
averaged across each 1-min period after four tone presentations.  The V/V group differed from 
the V/Pr group (p = 0.04).  All groups consisted of 12 subjects. 
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An interaction between the two fell just short of significance (F(1,44) = 3.91, p = 0.054).  
Post hoc analysis revealed a significant difference between subjects conditioned and 
tested on VEH (V/V) and those conditioned on VEH and tested on PROG (V/Pr; p < 
0.05) and a trend towards significance between subjects conditioned and tested on 
PROG (Pr/Pr) and those conditioned on VEH and tested on PROG (V/Pr; p = 0.052).   
Hormone assay 
 Subjects receiving subcutaneous injections of PROG had significantly higher 
levels of plasma PROG compared to VEH injected subjects (t(46) = -16.88, p < 0.0001).   
 
Discussion 
 The results presented here suggest naturally fluctuating PROG levels across the 
estrous cycle can contribute to state-dependent contextual fear in female rats.  This 
finding is largely driven by high levels of freezing in the group conditioned and tested in 
DI (D/D) compared to the low freezing levels in the group conditioned in DI and tested 
in PRO (D/P).  For the first time, this suggests naturally cycling levels of PROG may act 
as an interoceptive contextual cue that becomes associated with the exteroceptive 
aversive context following Pavlovian fear conditioning.  In an OVX model with 
exogenous PROG administration, hormone treatment was not associated with state 
dependence in contextual fear.  However, for cued fear, the decreased freezing levels in 
the group conditioned under VEH and tested under PROG (V/Pr) compared to those in 
the group conditioned and tested under VEH (V/V) suggest that a state-dependent 
mechanism is possible.  PROG administration after OVX had slight reductions in 
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freezing across all groups during contextual fear testing regardless of when it was 
administered.  In contrast, following cued fear testing, subjects that only received PROG 
prior to testing (V/Pr) had reduced freezing. In all cases, however, freezing levels were 
elevated above 50% throughout testing, suggesting robust fear recall in all groups.  
While OVX models are valuable, they do not necessarily replicate intact cycling states.  
These models negate the impact of fluctuating hormones across the estrous cycle and 
instead give fixed amounts of hormones. Therefore, it cannot be assumed that OVX 
experiments will model naturally cycling experiments. 
 Previously, we found male rats infused with ALLO in the BNST prior to 
conditioning resulted in enhanced freezing during acquisition (Acca et al., 2017).  
Because PROG is a precursor to ALLO, elevated PROG levels in females could have 
also resulted in increased freezing during acquisition.  However, high PROG levels 
during conditioning in naturally cycling and OVX female rats did not affect freezing 
during fear acquisition.  PROG levels in PRO groups and PROG groups would be 
expected to be within normally elevated physiological levels during acquisition and 
therefore supraphysiological levels of PROG or ALLO may be needed for this enhanced 
freezing effect.  In addition, the experiments presented here focus on systemic changes 
in hormone levels that are more likely to affect the whole brain whereas previously only 
the BNST was targeted.  Competing actions of hormones in different brain regions may 
have erased this effect.   
 Upon first glance, our results from naturally cycling PROG levels in female rats 
on contextual fear follow existing literature.  Previous studies involving tests of fear and 
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anxiety suggest animals tested in PRO or OVX with hormone replacement have reduced 
fear levels compared to other estrous cycle stages or no hormone replacement (Frye et 
al., 2000; Gupta et al., 2001; Marcondes et al., 2001; Milad et al., 2009; Toufexis et al., 
2004).  However, in this case not all subjects tested in PRO had decreased freezing; 
those conditioned and tested in PRO had elevated levels of fear, suggesting state- 
dependent effects.  These effects were asymmetrical, as those trained in PRO and tested 
in DI maintained elevated freezing levels.  Clinically, asymmetrical state-dependent 
effects have also been reported with memory recall after alcohol consumption (Goodwin 
et al., 1969).  Gonadal steroid hormones, therefore, can act as interoceptive cues such 
that memories are better recalled when in the same hormone state as when the memory 
was learned.  It is not just hormonal state during testing that matters, but an interaction 
between hormone levels during both conditioning and testing.   
 To our knowledge this is the first time state-dependent effects of naturally 
cycling hormones on contextual fear conditioning have been reported.  Previously, 
similar studies using Pavlovian fear conditioning followed by passive avoidance testing 
in both naturally cycling females or in same or different stages of pregnancy, found no 
evidence for state-dependent effects.  However, in an OVX model with PROG 
administration, asymmetrical state-dependent effects were found after a 1-day interval 
between training and testing, but not at 7 days (Ebner et al., 1981). The difference in 
results found in Ebner et al. (1981) and here could be due to a number of factors.  First, 
passive avoidance testing was used instead of fear recall and secondly, different stages 
of the estrous cycle were examined, PRO and estrus.  In another study in which both 
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conditioning and testing occurred either during PRO or estrus, lower levels of contextual 
fear were observed in PRO animals compared to estrus animals (Markus and Zecevic, 
1997).  However, in this study, there was no comparison made to mismatched cycle 
phases during conditioning and testing and differences in rat strains and duration of time 
between conditioning and testing are all possible factors.  Time between conditioning 
and testing in our study was less than a week whereas in Markus & Zecevic (1997), two 
weeks elapsed between conditioning and testing.  This, along with the results from Ebner 
et al. (1981), raises interesting questions as to how salient interoceptive cues remain over 
time.   
 Given the behavioral effects of circulating PROG, we were surprised to find no 
differences in c-fos expression in the BNST between conditioned and tested subjects and 
those that never received shocks (CS- groups) but otherwise experienced the same 
behavioral tests.  Previous studies in female rats involving restraint stress found 
differences in Fos reactivity in BNST, specifically in BNST-OV and BNST-FU 
(Sterrenburg et al., 2012).  Even though rats may not be learning a tone-shock 
association in a distinct context in the CS- control group, they are still learning and 
acquiring contextual information.  Using a home control may have revealed greater 
differences because Fos would have been assessed outside of the conditioning context. 
Many subnuclei within BNST did not reveal c-fos differences between groups 
with matched and mismatched estrous cycle phases during conditioning and testing, 
which may be due to the diverse subregions and intricate competing connections.  For 
instance, BNST-OV is thought to exert an anxiogenic profile through its rich 
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corticotropin releasing factor (CRF) neurons (Kim et al., 2013; Lee and Davis, 1997; 
Sahuque et al., 2006), even though BNST-OV neurons are also GABAergic (Dabrowska 
et al., 2013).  In support of this, it was recently shown that optogenetically silencing 
projections from CRF-containing neurons in the lateral region of the central amygdala to 
CRF-containing neurons in the lateral region of BNST during training, reduced fear 
retention (Asok et al., 2017).  Although no differences were found in our study, more 
precise targeting of specific neuronal types may have yielded differences.  In the ventral 
BNST, BNST-FU also contains CRF neurons (Phelix and Paull, 1990) along with 
glutamatergic cells (Csáki et al., 2000), however, most neurons in this area are 
GABAergic (Radley et al., 2009).  Despite this, the minority glutamatergic cells in the 
ventral BNST appear to have excitatory affects on the hypothalamus (Choi et al., 2007) 
and thus drive anxiety behaviors.  There are differing reports on the role of BNST-AM 
in anxiety.  BLA inputs to BNST-AM drive anxiolytic behavior on the elevated plus 
maze (Kim et al., 2013) whereas in another study, BNST-AM neurons fired more during 
freezing behavior in response to CS presentations and contextual fear (Haufler et al., 
2013).  BNST is also comprised of multiple intrinsic connections which further 
confound its role in anxiety behavior (Dong et al., 2001b; Dong and Swanson, 2004; 
2006).   
Interestingly, BNST-AL revealed differences with those trained in DI having 
greater Fos expression compared to those trained in PRO yet behaviorally, PRO trained 
subjects had slightly higher fear levels compared to DI trained subjects as evidenced by 
an overall significant main effect of cycle phase at conditioning.  This is in line with 
  104 
previously described work that suggests BNST-AL is anxiolytic (as reviewed in Gungor 
and Pare, 2016, although see Gungor and Pare, 2014; Sink et al., 2011).  Our analysis 
parsed BNST-OV from BNST-AL, and revealed no such differences in BNST-OV.  
Given the intricate connections both within and outside this region along with the 
differences in neuronal subtypes, solely measuring neuronal activation may not be 
sufficient to detect state-dependent effects of hormonal actions within BNST.  Recent 
work found state-dependent effects of gaboxadol in the dorsal hippocampus were 
mediated by miR-33, which may be another mechanism to explore in the BNST 
(Jovasevic et al., 2015).  Our previous results found state-dependent actions of 
supraphysiological levels of ALLO in the BNST of male rats (Acca et al., 2017) and 
although the current results of Fos patterns in BNST did not correlate with freezing 
behavior, it does not exclude its role in mediating the observed behavior seen here in 
females.  It should be noted that other brain regions including the prefrontal cortex, 
ventral hippocampus, BLA, and CEA also showed no differences across groups in Fos 
immunoreactivity (data not shown).   
 We replicated our naturally cycling design with OVX rats with PROG or VEH 
treatment prior to conditioning as well as contextual and cued fear testing and did not 
find the same state-dependent effects as we did with intact female rats across the estrous 
cycle.  Estrous cycles were not tracked in Experiment 2 between arrival and surgery and 
given the short interval between OVX and behavior, residual hormones may still be in 
circulation and therefore all subjects may not have been in the same physiological state 
at the onset of behavior.  Ovariectomy results in a loss of fluctuating hormone levels 
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across the estrous cycle and accompanying that, a loss in fluctuating receptor profiles.  
For instance, GABAA receptor subtypes fluctuate over the estrous cycle with changing 
hormone levels (Clark et al., 1998; Maguire et al., 2005) and in response to estrogen 
following OVX (Herbison and Fénelon, 1995).  In addition, estrogen is known to prime 
PROG receptors (Parsons et al., 1982) and in our OVX model with PROG replacement, 
PROG receptors may not be in abundance.  Given our experimental design, we cannot 
conclude that the actions of PROG in intact or OVX rats are the product of PROG or its 
conversion to any of its metabolites, including ALLO.  Further work is needed to specify 
this. 
 The work presented here suggests PROG, particularly in intact females, can 
contribute to state-dependent contextual and cued fear.  Currently most studies do not 
consider the interaction of hormonal state during conditioning and testing, yet our work 
provides evidence of its importance.  Clinically, this may have important implications 
when considering exposure therapy in female patients.   
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CHAPTER V 
CONCLUSIONS 
 
Summary of Results 
The work presented here stems from earlier research demonstrating that male rats 
have greater levels of contextual fear compared to female rats (Maren et al., 1994).  This, 
along with evidence of sex differences in fear and anxiety disorders in clinical 
populations, suggests hormones and their metabolites may influence fear.  Chapter 1 
introduces this phenomenon and details previous research on gonadal hormones and 
their effects of fear behavior in both human and animal studies.  In particular, this 
dissertation focuses on progesterone (PROG) and its metabolite, allopregnanolone 
(ALLO).  PROG, which is less studied in the fear literature compared to estrogen, 
fluctuates throughout the estrous cycle with highest levels observed during proestrus.  
However, much of its actions in fear and anxiety behavior are attributed to its 
metabolite, ALLO.  Through its actions at GABAA receptors, ALLO has well 
established anxiolytic properties (Akwa et al., 1999; Bitran et al., 1993; Frye and Walf, 
2002) on a number of different tasks.  Furthermore, PROG and ALLO appear to 
preferentially affect contextual fear as opposed to cued fear (Pibiri et al., 2008; 
Rabinowitz et al., 2014; Toufexis et al., 2004).  Due to its anxiolytic properties and 
modulation of contextual fear, ALLO may therefore play an important role in mediating 
the observed sex differences.  I focused the efforts here on analyzing the effects of 
ALLO in the BNST because of its role in contextual fear and as a site of hormonal 
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regulation.  The overarching goal was to examine the effects of ALLO in the BNST on 
mediating observed sex differences seen in fear conditioning. 
In Chapter 2, I successfully demonstrated that ALLO’s actions in the BNST 
affect contextual fear in both males and females.  The opposite hormonal state was 
created in each sex by increasing BNST ALLO levels in males and decreasing BNST 
ALLO levels in females to reverse the typical behavioral profile.  Following fear 
conditioning, administration of intra-BNST ALLO in males significantly reduced 
contextual fear but had no effect on cued fear.  Conversely, in females, blocking the 
synthesis of ALLO or binding of ALLO to GABAA receptors increased contextual fear, 
but again had no effect on cued fear.  Given prior research on the role of the BNST in 
contextual versus short duration cued fear, the lack of effects during tone testing was not 
surprising.  However, the bi-directional role ALLO played in the BNST suggests it is a 
site of hormonal regulation of contextual fear and may, in part, mediate the observed sex 
differences in contextual fear in rats.  ALLO levels are higher in females throughout 
most of the estrous cycle compared to males and proestrus, when PROG levels and 
subsequently ALLO levels are higher, may act as an anxiolytic period in female rats.  
However, the effects of ALLO in male rats was possibly due to state-dependent 
mechanisms as subjects were trained in the absence of drug and only received ALLO or 
VEH infusions prior to testing.  This led to testing for state-dependent effects of intra-
BNST ALLO infusions on contextual fear in Chapter 3. 
Surprisingly, ALLO infusions into the BNST resulted in state-dependent 
contextual fear in male rats.  State-dependent effects have not previously been reported 
  108 
with hormones or their metabolites in the BNST; only the hippocampus had previously 
been identified as a specific brain region that mediates state-dependent memories 
(Jovasevic et al., 2015).  To ensure this was specific to the BNST and not to ALLO 
itself, the same experiment was replicated in the BLA, a region that previously has been 
shown to be state-independent with other drugs, including GABAergic modulators.  
ALLO effects in the BLA proved to be state-independent and affected both contextual 
and cued fear.  Therefore, state-dependent effects of ALLO are unique to the BNST.  In 
an experiment examining the effects of external vs. internal context shifts, both appeared 
to have equal influence of freezing behavior.  This was unexpected as it was thought that 
external contextual cues are more salient than internal contextual cues. 
The results from Chapter 3 prompted me to analyze the state-dependent effects of 
naturally occurring hormonal fluctuations in female rats.  Specifically, I focused on 
PROG because it is the precursor to ALLO.  Cycling PROG levels in female rats results 
in asymmetrical state-dependent effects on contextual fear that are driven by high fear 
levels in animals trained and tested in high PROG states and low fear levels in animals 
trained in a low PROG state and tested in a high PROG state.  Previous literature 
suggests that proestrus, when ovarian steroid levels are high, is a period of lower fear 
and anxiety, however, the present results show that hormone state during both training 
and testing are important.  The behavioral effects, however, could not be localized to the 
BNST through mapping of neuronal activation patterns, although there were effects of 
training state in the BNST-AL.  More work is necessary to identify if the state-dependent 
effects of PROG on contextual fear are mediated by the BNST or other brain regions.  In 
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an OVX model, PROG treatment was associated with state-dependent effects on cued 
but not contextual fear.   
The work presented here began by examining the effects of ALLO in the BNST 
in male and female rats and has evolved to uncover a novel role of hormones in fear 
memories.  As such, it has strong implications on how future experiments will be 
designed and conducted.  Taking into consideration hormonal state during training or 
testing alone is not sufficient; the interaction between to the two is just as important.  
This provides novel evidence for the role of hormones and their metabolites in creating 
internal contextual cues that affect the recall of memories.     
 
BNST and Contextual Fear, Expanded 
 Prior research identified the BNST as important for contextual fear, but not cued 
fear.  The work presented here, along with other recent research presents evidence that 
how the field defines and separates contextual vs. cued fear needs to be reevaluated.  
Initially, it was first proposed that the BNST is not involved in discrete cues such as the 
short duration cues used in the work here (Gewirtz et al., 1998; Ledoux et al., 1988).  
Instead, it was involved in contextual fear responses (Hammack et al., 2004; Sullivan et 
al., 2004; Zimmerman and Maren, 2011).  What constitutes a context, however, is a 
more critical question.  Long duration cues are affected by BNST manipulations 
(Waddell et al., 2006; Walker et al., 2009) and when the shock is presented in the first 
minute of contextual fear conditioning as opposed to after 10-min context exposure, 
inactivation of the BNST does not affect freezing behavior (Hammack et al., 2015).  
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Together, this suggests that the BNST is not strictly involved in contextual fear over 
cued fear, but that the timing and duration of the CS is important.  One interpretation 
may be that the longer a discrete cue is presented, the more likely it is to be incorporated 
as part of the external context; shocks early on during training were not affected by 
BNST manipulations (Waddell et al., 2006).  Either way, Hammack et al. (2015) 
suggests stimulus duration is necessary for BNST recruitment during contextual fear 
processing.  In the work here, neurosteroids in the BNST are present throughout the 
entire context test in Chapter 2 and throughout training and testing in Chapter 3, 
therefore they create an interoceptive context that lasts the duration of the behavioral 
task.   
 There are reports though of BNST manipulations that do affect short duration 
cued fear.  For instance, intra-BNST muscimol injections enhanced fear potentiated 
startle (Meloni et al., 2006) and BNST recordings found neuronal responses in the 
BNST-AL and BNST-AM to discrete CSs (Haufler et al., 2013).  Clearly, more work is 
needed to examine the direct role of the BNST in mediating fear responses, including its 
novel role in state-dependent memories.  The BNST is comprised of heterogeneous 
neuronal subtypes with diverse receptors.  Calcitonin gene-related peptide (CGRP), 
corticotrophin releasing factor (CRF), and pituitary adenylate cyclase-activating 
polypeptide (PACAP) have all been shown to affect anxiety behaviors (Hammack et al., 
2010; Lee and Davis, 1997; Sink et al., 2013).  Given recent technological advancements 
in the field, more precise manipulations of neuronal subtypes can be targeted to 
understand the more detailed role the BNST plays in fear and anxiety.  The state- 
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dependent effects of ALLO are likely mediated through its actions at GABAA receptors 
and therefore increase the inhibitory tone on the BNST, leading to disinhibition due to 
the majority of GABAergic neurons in this area.  However, because the ALLO 
manipulations here globally affected the BNST and were not specifically targeting 
neuronal subtypes, it is unclear if inhibiting specific subtypes contributes to state- 
dependent learning or if global disinhibition affected local circuitry.  As more research is 
done to examine the specific role of the BNST in fear and anxiety, attention must be paid 
to state-dependent effects and how interoceptive states contribute. 
  
Hormones, Metabolites, and State-Dependent Learning 
  The results presented here found state-dependent effects of ALLO in male rats 
and of PROG in naturally cycling female rats, which raises an interesting role for 
hormones in memory processing.  Hormone states are known to affect memory in a 
variety of tasks in both human and rodent studies.  Outside of fear conditioning, PROG 
has been shown to enhance consolidation of memories in the Morris water maze (Frye et 
al., 2009).  However, when given prior to training, ALLO impairs learning (Johansson et 
al., 2002).  Estrogen dose-dependently affects cognitive performance with high levels 
impairing and low levels facilitating working memory performance (Holmes et al., 2002; 
Wide et al., 2004).  Of course, given the outcome of the present work it is possible that 
the impairments in these tasks represent state-dependent generalization deficits. 
 Within the domain of aversive learning, recent work has implicated gonadal 
steroids in the extinction of fear.  During extinction, the CS is presented in the absence 
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of the US and after repeated presentations the CR gradually fades. Numerous studies 
demonstrate that extinction results in a new memory and is not simply an erasure of the 
original fear memory (Maren, 2011).  Indeed, extinction memories are context 
dependent (Maren et al., 2013).  Although most studies only consider exteroceptive 
context, extinction memories may be susceptible to interoceptive state-dependent effects 
as well.  Currently, research on hormones in extinction learning suggest that extinction 
learning is optimal in proestrus, when estrogen and PROG levels are elevated compared 
to metestrus (Milad et al., 2009).  Similarly, OVX rats treated with estradiol had 
decreased freezing during both context testing  and extinction trials (Chang et al., 2009; 
Gupta et al., 2001).  However, these designs involve extinguishing and testing fear in 
different hormonal states that are associated with different interoceptive contexts.  It is 
possible that these studies underestimate the magnitude of extinction, because of the 
interoceptive context shift in between extinction training and the retention test.  
 Clinical research also demonstrates differences in fear extinction across the 
menstrual cycle in women with and without a clinical diagnosis.  Higher estrogen levels 
are associated with more robust extinction memory (Milad et al., 2010; Wegerer et al., 
2014) and fear inhibition (Glover et al., 2013).  However, a recent report suggests the 
effects of menstrual cycle phase on extinction learning may depend on if the subjects 
have been diagnosed with PTSD.  Impaired retention of extinction learning was found in 
the midluteal phase of the menstrual cycle in women with PTSD when estrogen and 
PROG levels are high, whereas those without a diagnosis of PTSD had greater extinction 
retention in this phase (Pineles et al., 2016).  The experimental design in these 
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experiments does not allow for testing of state-dependent memory.  Of course, the 
human menstrual cycle is much longer than that in the rat.  It remains to be seen if the 
state-dependent effects of cycling hormones on contextual fear are as robust across the 
human menstrual cycle.  It is well known that fear memories persist even after long 
passages of time, yet it is not known how robust interoceptive context shifts affect 
retention across these intervals.  Therefore, cycling gonadal hormones may not show 
state-dependent effects on fear learning due to the longer cycle length.  Regardless, 
understanding the role of gonadal hormones in state-dependent memories, particularly in 
cycling women is critical for developing better sex-specific therapeutic options for 
treating fear and anxiety disorders in women.  If hormonal state-dependent fear 
memories are present in clinical populations, attention must be given to when the trauma 
occurred and how that interacts with hormone state during therapeutic interventions such 
as exposure therapy.   
Potential mechanisms for state dependence 
 The state-dependent effects localized to the BNST in Chapter 3 are likely due to 
the actions of ALLO at GABAA receptors, however the mechanisms underlying it 
remain unknown.  In the hippocampus, miR-33 was found to play a role in the state-
dependent effects of gaboxadol on contextual fear (Jovasevic et al., 2015).  Given both 
ALLO and gaboxadol act at GABAA receptors, it is reasonable to speculate that ALLO 
may act as an interoceptive cue in the dorsal hippocampus as well.  However, on a 
variety of behavioral tasks, intra-hippocampal ALLO did not have any effect (Engin and 
Treit, 2007; Mòdol et al., 2011, although see Frye and Walf, 2002).  These tasks, aside 
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from passive avoidance, are innate behavioral tasks and therefore missing the learning 
component that is essential for state-dependent effects.  Ethanol also acts as an 
interoceptive cue encoded by the hippocampus.  Shifting interoceptive states between 
extinction and fear relapse resulted in a return of fear that was reversed with AMPAR 
antagonists (Yoo et al., 2017).  Although this study did not explicitly test for state-
dependent effects, ethanol has been reported to induce state-dependent learning albeit 
this was in systemic studies (Nakagawa and Iwasaki, 1995; 1996).  Therefore, the 
control of GABAA receptor expression through miR-33 and also AMPA receptors within 
the hippocampus may underlie interoceptive context cues.    
 The BNST is rich in neuromodulators such as CRF, dopamine, norepinephrine, 
serotonin, pituitary adenylate cylase-activating peptide (PACAP), and calcitonin gene 
related peptide (CGRP; Daniel and Rainnie, 2016; Hammack et al., 2009; Sink et al., 
2013).  Whether other peptides such as these also contribute to state-dependent effects 
remains to be explored.  It is unclear how the BNST encodes interoceptive contexts and 
given its diversity, it is interesting to speculate if other peptides in this area would have 
similar results.  Indeed, norepinephrine has been implicated in state-dependent effects on 
the extinction of inhibitory avoidance (Rosa et al., 2014).  With supraphysiological 
levels of ALLO, there is probably a global inhibitory tone on the BNST following 
administration, which may be necessary for encoding of interoceptive cues; it is unclear 
how “strong” of a shift is needed to result in state-dependent effects.  However, more 
minute changes with some of the neuromodulators mentioned above that regularly affect 
BNST activity may also constitute interoceptive shifts.    
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Incorporating Sex Differences in Fear Research  
 Although the work here evolved to examine the role of hormones in state-
dependent fear memories, evidence still suggests that gonadal hormones contribute to 
and mediate sex differences in fear and anxiety.  However, recent reports from combat 
veterans are beginning to report smaller sex differences in the rates of PTSD compared 
to earlier work.  Given changes in military protocol, women now face more combat than 
before.  When examining combat-related stressors to post-deployment mental health, 
women did not fair worse compared to men (Vogt et al., 2011).  Furthermore, another 
study did not find sex differences in PTSD following deployment (Street et al., 2013). 
Yet among healthcare professionals in the military, women were more likely to report 
PTSD symptoms compared to men (Gibbons et al., 2012).  As participation of women in 
combat areas increases, more research will be needed to see if sex differences still exist 
in this setting, or if there are underlying differences in trauma type or readjustment once 
they return that contribute (Gilmore et al., 2016; Smith et al., 2017).  Regardless, outside 
military-specific studies, sex differences are still robust with women far exceeding men 
across the lifespan (Ditlevsen and Elklit, 2010).   
 Because NIH now mandates research in both males and females, even at the 
preclinical level, it is important to ensure studies are conducted with an appreciation of 
cyclical hormonal effects on learning and memory.  Because most existing literature that 
formed the basis of the field was done in males, it is important to make sure assumptions 
exist when including females.  For instance, Pavlovian fear conditioning uses freezing 
behavior as a measure of fear and all other movement outside that suggests an absence of 
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fear.  Gruene and colleagues (2015) identified a novel active fear response which they 
coined “darting” in which female rats are more likely to quickly “dart” across the 
behavioral chamber as a fear response, instead of freezing.  Darting behavior increases 
with conditioning trials and decreases throughout extinction, all characteristics of 
learned fear behavior (Gruene et al., 2015).  Given that female rodents are known to 
generally be more active than males (Fernandes et al., 1999; File, 2001), it is not 
surprising that different strategies might be utilized between sexes when responding to 
threat.  While the female rodent work conducted in this dissertation did not display 
darting behavior, it is still important to consider.   
 
Future Directions 
 Here we show clear state-dependent effects on contextual fear via intra-BNST 
ALLO, but not via intra-BLA ALLO.  Recent work demonstrates the dorsal 
hippocampus is also involved in state-dependent contextual fear via gaboxadol 
(Jovasevic et al., 2015).  ALLO has anxiolytic actions in the dorsal hippocampus as well 
(Bitran et al., 2000; Mòdol et al., 2011).  Therefore it would be worthwhile to examine 
its role in this brain region as well.  Jovasevic et al. (2015) identified miR-33, a micro-
RNA that regulates different GABA related proteins, as influential for maintaining the 
state-dependent effects.  The same mechanisms may be conserved in the BNST and 
given the diverse GABAA subtypes in the BNST (Pirker et al., 2000; Wisden et al., 
1992), it may involve similar mechanisms as the hippocampus.    
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 Our results on state-dependent contextual fear in intact females only consider the 
role of PROG.  While the surge in PROG follows the rise and fall of estrogen, the 
studies here do not consider the effects of estrogen.  In the OVX model with PROG 
replacement, results did not replicate the naturally cycling model.  With only exogenous 
PROG administration, estrogen levels are presumably very low.  Therefore, estrogen 
most likely contributes in some manner to the state-dependent effects on contextual fear 
in female rats.  OVX studies using estrogen in place of PROG or both hormones to 
mimic natural fluctuations would be useful to more fully appreciate this effect.  Both 
intact and OVX models also do not account for the differential actions of PROG vs. 
ALLO.  To differentiate between the two, blocking the synthesis of ALLO from PROG 
or the binding of ALLO at GABAA receptors as done in Chapter 2 are possible options.    
  ALLO, however, does mediate contextual fear in females via the BNST as seen 
in Chapter 2.  By reducing ALLO levels or its binding with GABAA receptors, 
contextual fear was enhanced.  Given the disruption in ALLO levels in patients with 
PTSD (Rasmusson et al., 2006), a further understanding of the role ALLO plays in fear 
and anxiety is critical.  GABAA receptor subunits change across the estrous cycle, yet 
exactly how they change, and where the changes are located within the BNST remain to 
be discovered.  As a more detailed understanding of the circuitry of the BNST evolves, a 
more precise understanding of how ALLO affects neuronal activity can be determined.   
 In summary, more work is needed to understand how hormones and their 
metabolites influence fear.  The sex differences in human psychiatric diagnoses and 
abundant research in both rodent and clinical models identify a role for hormones and 
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their metabolites in contributing to fear and anxiety.  With more research, sex-specific 
therapies can be developed to ease the burden on individuals and society.   
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